<SEC-DOCUMENT>0001654954-20-000287.txt : 20200110
<SEC-HEADER>0001654954-20-000287.hdr.sgml : 20200110
<ACCEPTANCE-DATETIME>20200110163658
ACCESSION NUMBER:		0001654954-20-000287
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20200110
DATE AS OF CHANGE:		20200110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ENDRA Life Sciences Inc.
		CENTRAL INDEX KEY:			0001681682
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				260579295
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-235883
		FILM NUMBER:		20521510

	BUSINESS ADDRESS:	
		STREET 1:		3600 GREEN COURT
		STREET 2:		SUITE 350
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48105
		BUSINESS PHONE:		734-335-0468

	MAIL ADDRESS:	
		STREET 1:		3600 GREEN COURT
		STREET 2:		SUITE 350
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48105

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Endra Inc.
		DATE OF NAME CHANGE:	20160805
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ndra_s3.htm
<DESCRIPTION>S-3
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
As filed with the Securities and Exchange Commission on January 10,
2020</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Registration
No. 333-</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000">
<!--style header--><br></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES SECURITIES AND EXCHANGE COMMISSION</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
FORM S-3</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF
1933</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 16px">
ENDRA LIFE SCIENCES INC.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Exact name of registrant as specified in its charter)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Delaware</font></div>
</td>
<td style="vertical-align: top; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
26-0579295</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(State or other jurisdiction of incorporation or
organization)</font></div>
</td>
<td style="vertical-align: top; width: 20%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">ENDRA
Life Sciences Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">3600
Green Court, Suite 350</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ann
Arbor, MI 48105</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(734)
335-0468</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Address, including zip code, and telephone number, including area
code, of registrant&#x2019;s principal executive
offices)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Francois
Michelon</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">ENDRA
Life Sciences Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">3600
Green Court, Suite 350</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ann
Arbor, MI 48105</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(734)
335-0468</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Name, address, including zip code, and telephone number, including
area code, of agent for service)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Copy
to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Mark R.
Busch</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">K&amp;L
Gates LLP</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">214
North Tryon Street, 47th Floor</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Charlotte,
North Carolina 28202</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(704)
331-7440</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
From time to time after the effective date of this registration
statement.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
(Approximate date of commencement of proposed sale to the
public)</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If the
only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check
the following box. &#x2610;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If any
of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box.
&#x2612;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same
offering. &#x2610;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier
effective registration statement for the same offering.
&#x2610;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is a registration statement pursuant to General Instruction
I.D. or a post-effective amendment thereto that shall become
effective upon filing with the Commission pursuant to Rule 462(e)
under the Securities Act, check the following box.
&#x2610;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If this
Form is a post-effective amendment to a registration statement
filed pursuant to General Instruction I.D. filed to register
additional securities or additional classes of securities pursuant
to Rule 413(b) under the Securities Act, check the following box.
&#x2610;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of
&#x201C;large accelerated filer,&#x201D; &#x201C;accelerated
filer,&#x201D; &#x201C;smaller reporting company&#x201D; and
&#x201C;emerging growth company&#x201D; in Rule 12b-2 of the Exchange
Act (check one):</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Large
accelerated filer &#x2610;</font></div>
</td>
<td style="vertical-align: top; width: 45%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Accelerated
filer &#x2610;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 55%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Non-accelerated
filer &#x2612;</font></div>
</td>
<td style="vertical-align: top; width: 45%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Smaller
reporting company &#x2612;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 55%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 45%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Emerging
growth company &#x2612;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided to
Section 7(a)(2)(B) of the Securities Act. &#x2612;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000">
<!--style footer--><br></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr"><br></div>
<div id="pb" style="text-align: center; break-after: page; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: rgb(255, 255, 255);">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CALCULATION OF REGISTRATION FEE</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:2px;margin-left:0px;"><font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">Title
of Each Class of Securities to be Registered</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Amount to be
Registered <font style="vertical-align:top;font-size:70%;font-family:Times New Roman;">(1)(2)</font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Proposed Maximum
Offering Price Per Share <font style="vertical-align:top;font-size:70%;font-family:Times New Roman;">(3)</font></font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Proposed Maximum
Aggregate Offering Price</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 2px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Amount of
Registration Fee</font></div>
</font><font style="text-align: left; padding-bottom: 2px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Common stock, par
value $0.0001 per share</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">25,644,002</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">1.85</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">47,313,183.69</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">6,141.25</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">(1)&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In accordance with
Rule 416 under the Securities Act of 1933, as amended (the
&#x201C;Securities Act&#x201D;), this registration statement shall be
deemed to cover an indeterminate number of additional shares to be
offered or issued from stock splits, stock dividends or similar
transactions with respect to the shares being
registered.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">(2)&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Includes (i)
904,526 shares of common stock, par value $0.0001 per share
(&#x201C;Common Stock&#x201D;), issued in a private placement that
closed on December 11, 2019 (the &#x201C;First Private
Placement&#x201D;); (ii) 7,191,873<font style="font-size: 13px">&#xA0;</font>shares of Common Stock that are
issuable upon conversion of the Company&#x2019;s Series A
Convertible Preferred Stock, par value $0.0001 per share (the
&#x201C;Series A Preferred Stock&#x201D;), issued in the First
Private Placement; (iii) 8,096,399 shares of Common Stock that are
issuable upon exercise of the warrants that were issued with the
Series A Preferred Stock, including warrants issued to the
placement agent in the First Private Placement; (iv) an estimated
8,660,410 shares of Common Stock that may be issuable in respect of
accrued but unpaid dividends on shares of Series A Preferred Stock;
(v) 232,461<font style="font-size: 13px">&#xA0;</font>shares of
Common Stock that are issuable upon conversion of the
Company&#x2019;s Series B Convertible Preferred Stock, par value
$0.0001 per share (the &#x201C;Series B Preferred Stock&#x201D;),
issued in a private placement that closed on December 23, 2019 (the
&#x201C;Second Private Placement&#x201D;); (vi) 278,948<font style="font-size: 13px">&#xA0;</font>shares of Common Stock that are
issuable upon exercise of the warrants that were issued with the
Series B Preferred Stock, including warrants issued to the
placement agent in the Second Private Placement; and (vii) an
estimated 279,385<font style="font-size: 13px">&#xA0;</font>shares
of Common Stock that may be issuable in respect of accrued but
unpaid dividends on shares of Series B Preferred
Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;(3)&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Estimated solely
for the purpose of calculating the registration fee pursuant to
Rule 457(c) under the Securities Act. Based on the average of the
high and low reported trading prices of Common Stock as reported on
the Nasdaq Capital Market on January 8, 2020.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
The Registrant hereby amends this Registration Statement on such
date or dates as may be necessary to delay its effective date until
the Registrant shall file a further amendment which specifically
states that this Registration Statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of
1933, as amended, or until the Registration Statement shall become
effective on such date as the Securities and Exchange Commission,
acting pursuant to said Section 8(a), may determine.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">i</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #FF0000; font-weight: bold; font-family: Times New Roman; font-size: 13px">
The information in this prospectus is not complete and may be
changed. The selling stockholders may not sell these securities
until the registration statement filed with the Securities and
Exchange Commission is effective. This prospectus is not an offer
to sell these securities and the selling stockholders are not
soliciting an offer to buy these securities in any state where the
offer or sale is not permitted.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #FF0000; font-family: Times New Roman; font-size: 13px">
Subject to completion, dated January 10, 2020</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ndra_s3000.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ENDRA Life Sciences Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Prospectus</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
25,644,002 Shares of Common Stock for sale by the Selling
Stockholders</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus relates to the resale or other disposition from time to
time of up to 25,644,002 shares of our common stock, par value
$0.0001 per share (&#x201C;Common Stock&#x201D;), in connection with
a private placement that closed on December 11, 2019 (the
&#x201C;First Private Placement&#x201D;) and a private placement that
closed on December 23, 2019 (the &#x201C;Second Private
Placement&#x201D;), by the persons described in this prospectus,
whom we call the &#x201C;Selling Stockholders,&#x201D; identified in
the section of this prospectus entitled &#x201C;Selling
Stockholders.&#x201D; Of these shares, (i) 904,526 shares were
issued in the First Private Placement; (ii) 7,191,873 shares are
issuable upon conversion of the Company&#x2019;s Series A
Convertible Preferred Stock, par value $0.0001 per share (the
&#x201C;Series A Preferred Stock&#x201D;), issued in the First
Private Placement; (iii) 8,096,399 shares are issuable upon
exercise of the warrants that were issued with the Series A
Preferred Stock, including warrants issued to Lake Street Capital
Markets, LLC (&#x201C;Lake Street&#x201D;) and its designees in
connection with Lake Street&#x2019;s services as placement agent in
the First Private Placement (collectively, the &#x201C;Series A
Warrants&#x201D;); (iv) an estimated 8,660,410 shares may be
issuable in respect of accrued and unpaid dividends on shares of
Series A Preferred Stock; (v) 232,461 shares are issuable upon
conversion of the Company&#x2019;s Series B Convertible Preferred
Stock, par value $0.0001 per share (the &#x201C;Series B Preferred
Stock&#x201D;), issued in the Second Private Placement; (vi) 278,948
shares are issuable upon exercise of the warrants that were issued
with the Series B Preferred Stock, including warrants issued to
Lake Street and its designees in connection with Lake
Street&#x2019;s services as placement agent in the Second Private
Placement (collectively, the &#x201C;Series B Warrants&#x201D;); and
(vii) an estimated 279,385 shares may be issuable in respect of
accrued and unpaid dividends on shares of Series B Preferred Stock
(all such shares of Common Stock described in (i) through (vii)
above, the &#x201C;Securities&#x201D;).</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
registering the Securities as required by the terms of the
registration rights agreement among the investors in the First
Private Placement, the investors in the Second Private Placement,
Lake Street and us. Such registration does not mean that the
Selling Stockholders will actually offer or sell any of the
Securities offered by this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Securities may be sold by the Selling Stockholders from time to
time in the open market, through privately negotiated transactions
or a combination of these methods, at market prices prevailing at
the time of sale or at negotiated prices. The distribution of the
Securities by the Selling Stockholders is not subject to any
underwriting agreement. We will not receive any proceeds from the
sale of the Securities by the Selling Stockholders, although we
will receive the exercise price of any exercised Series A Warrants
and Series B Warrants paid to us by the Selling Stockholders, which
will be used for working capital and general corporate purposes. We
will bear all expenses of registration incurred in connection with
this offering, but all selling and other expenses incurred by the
Selling Stockholders will be borne by them.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
Common Stock is traded on the Nasdaq Capital Market under the
symbol &#x201C;NDRA.&#x201D; On January 8, 2020, the last reported
sale price for our Common Stock was $1.81 per share. The warrants
issued in our May 2017 initial public offering are listed on the
Nasdaq Capital Market under the symbol &#x201C;NDRAW;&#x201D;
however, the Series A Warrants and Series B Warrants issued in the
First Private Placement and Second Private Placement, respectively,
are not so listed.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
an &#x201C;Emerging Growth Company&#x201D; as defined in the
Jumpstart Our Business Startups Act of 2012 and, as such, have
elected to comply with certain reduced public company reporting
requirements for this prospectus and future filings. See
&#x201C;Prospectus Summary &#x2212; Implications of Being an Emerging
Growth Company.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Our business and an investment in the Securities involve a high
degree of risk. Before making any investment in the Securities, you
should read and carefully consider risks described in the
&#x201C;Risk Factors&#x201D; section beginning on page 9 of this
prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You
should rely only on the information contained in this prospectus or
any prospectus supplement or amendment hereto. We have not
authorized anyone to provide you with different information. This
prospectus may only be used where it is legal to sell the
Securities. The information in this prospectus is only accurate on
the date of this prospectus, regardless of the time of any sale of
Securities.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of the Securities
or determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal offense.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus is dated January , 2020.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">ii</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
You should rely only on the information contained in this
prospectus. We have not authorized any other person to provide you
with information that is different from that contained in this
prospectus. If anyone provides you with different or inconsistent
information, you should not rely on it. We take no responsibility
for, and can provide no assurance as to the reliability of, any
other information that others may give you. The Selling
Stockholders are offering to sell and seeking offers to buy the
Securities only in jurisdictions where offers and sales are
permitted. You should assume that the information contained in this
prospectus is accurate only as of the date of this prospectus,
regardless of the time of delivery of this prospectus or of any
sale of our Securities. Our business, financial condition, results
of operations and prospects may have changed since that date. We
are not making an offer of any Securities in any jurisdiction where
the offer is not permitted.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
TABLE OF CONTENTS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
PROSPECTUS SUMMARY</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">1</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
THE OFFERING</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">7</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
RISK FACTORS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">8</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">9</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
USE OF PROCEEDS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">10</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
DETERMINATION OF OFFERING PRICE</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">10</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
SELLING STOCKHOLDERS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">11</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
PLAN OF DISTRIBUTION</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">28</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
DESCRIPTION OF CAPITAL STOCK</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">30</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
LEGAL MATTERS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">33</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
EXPERTS</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">33</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
WHERE YOU CAN FIND MORE INFORMATION</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">34</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: middle; width: 85%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></div>
</td>
<td style="vertical-align: middle; width: 15%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px;">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">35</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<br></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">iii</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
<a name="_Toc15652596"><!--anchor--></a>ABOUT
THIS PROSPECTUS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus is part of a registration statement on Form S-3 that we
filed with the Securities and Exchange Commission (the
&#x201C;SEC&#x201D;) utilizing a &#x201C;shelf&#x201D; registration
process. Under this process, the Selling Stockholders may from time
to time, in one or more offerings, sell the shares of Common Stock
described in this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In addition, a prospectus supplement may also add, update or change
the information contained or incorporated in this prospectus. Any
prospectus supplement will supersede this prospectus to the extent
it contains information that is different from, or that conflicts
with, the information contained or incorporated in this prospectus.
The registration statement we filed with the SEC includes exhibits
that provide more detail of the matters discussed in this
prospectus. You should read and consider all information contained
in this prospectus and the related registration statement and
exhibits filed with the SEC and any accompanying prospectus
supplement in making your investment decision. You should also read
and consider the information contained in the documents identified
under the headings &#x201C;Where You Can Find More
Information&#x201D; and &#x201C;Incorporation of Certain Information
by Reference&#x201D; in this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Persons
who come into possession of this prospectus in jurisdictions
outside the United States are required to inform themselves about
and to observe any restrictions as to this offering and the
distribution of this prospectus applicable to that
jurisdiction.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unless
otherwise stated or the context requires otherwise, references to
&#x201C;ENDRA&#x201D;, the &#x201C;Company,&#x201D; &#x201C;we,&#x201D;
&#x201C;us&#x201D; or &#x201C;our&#x201D; are to ENDRA Life Sciences
Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">iv</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; page-break-after: always; width: 100%; height: 1px; background-color: #000000">
<!--page break line--></div>
<div id="hdr">
<div style="text-align: right; width: 100%"><font style="font-family: Times New Roman; font-size: 11px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
PROSPECTUS SUMMARY</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
The following summary highlights selected information contained
elsewhere in or incorporated by reference in this prospectus. This
summary is not complete and does not contain all of the information
that should be considered before investing in our Securities.
Potential investors should read the entire prospectus carefully,
including the more detailed information regarding our business
provided in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2018 (the &#x201C;Form 10-K&#x201D;) incorporated
herein by reference, the risks of purchasing our Securities
discussed under the &#x201C;Risk Factors&#x201D; section of the Form
10-K, and our financial statements and the accompanying notes to
the financial statements incorporated herein by
reference.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Our Company</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
leveraging experience with pre-clinical enhanced ultrasound devices
to develop technology for increasing the capabilities of clinical
diagnostic ultrasound, to broaden patient access to the safe
diagnosis and treatment of a number of significant medical
conditions in circumstances where expensive X-ray computed
tomography (&#x201C;CT&#x201D;) and magnetic resonance imaging
(&#x201C;MRI&#x201D;) technology is unavailable or
impractical.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
2010, we began marketing and selling our Nexus 128 system, which
combined light-based thermoacoustics and ultrasound to address the
imaging needs of researchers studying disease models in
pre-clinical applications. Building on this expertise in
thermoacoustics, we have developed a next-generation technology
platform &#x2014; Thermo Acoustic Enhanced Ultrasound, or TAEUS
&#x2014; which is intended to enhance the capability of clinical
ultrasound technology and support the diagnosis and treatment of a
number of significant medical conditions that currently require the
use of expensive CT or MRI imaging or where imaging is not
practical using existing technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We
ceased production of our Nexus 128 system as of January 1, 2019 and
stopped providing service support and parts for all existing Nexus
128 systems as of July 1, 2019 in order to focus our resources on
the development of our TAEUS technology.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Image below: An illustration of a typical cart-based ultrasound
system (left) with ENDRA&#x2019;s first-generation technology
(right).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<img src="ndra_s3001.jpg"></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">1</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font><br>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;padding-top: 0px; padding-bottom: 0px; margin-left: 0px; margin-right: auto; width: 100%;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: solid 2px #000000; border-left: solid 2px #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: solid 2px #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: solid 2px #000000; border-right: solid 2px #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: solid 2px #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Unlike the
near-infrared light pulses used in our legacy Nexus 128 system, our
TAEUS technology uses radio frequency, or RF, pulses to stimulate
tissues, using a small fraction (less than 1%) of the energy that
would be transmitted into the body during an MRI scan. The use of
RF energy allows our TAEUS technology to penetrate deep into
tissue, enabling the imaging of human anatomy at depths equivalent
to those of conventional ultrasound. The RF pulses are absorbed by
tissue and converted into ultrasound signals, which are detected by
an external ultrasound receiver and a digital acquisition system
that is part of the TAEUS system. The detected ultrasound is
processed into images using our proprietary algorithms and
displayed to complement conventional gray-scale ultrasound images.
The TAEUS imaging process is illustrated below:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ndra_s3002.jpg">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We believe that our
TAEUS technology has the potential to add a number of new
capabilities to conventional ultrasound and thereby enhance the
utility of both existing and new ultrasound systems and extend the
use of ultrasound technology to circumstances that either require
the use of expensive CT or MRI imaging systems or where imaging is
not practical using existing technology.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our TAEUS platform
is not intended to replace CT or MRI systems, both of which are
versatile imaging technologies with capabilities and uses beyond
the focus of our business. However, they are also expensive, with a
CT system costing approximately $1 million and an MRI system
costing up to $3 million. In addition, and in contrast to
ultrasound systems, due to their limited number and the fact that
they are usually fixed-in-place at major medical facilities, CT or
MRI systems are frequently inaccessible to patients.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">To demonstrate the
capabilities of our TAEUS platform, we have conducted various
internal ex-vivo laboratory experiments and limited internal
in-vivo large animal studies. In our ex-vivo and in-vivo testing,
we have demonstrated that the TAEUS platform has the following
capabilities and potential clinical applications:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman">Tissue Composition:
Our TAEUS technology enables ultrasound to distinguish fat from
lean tissue. This capability would enable the use of TAEUS-enhanced
ultrasound for the early identification, staging and monitoring of
NAFLD, a precursor to nonalcoholic steatohepatitis
(&#x201C;NASH&#x201D;), liver fibrosis, cirrhosis and liver
cancer.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman">Temperature
Monitoring: Our TAEUS technology enables traditional ultrasound to
visualize changes in tissue temperature, in real time. This
capability would enable the use of TAEUS-enhanced ultrasound to
guide thermoablative therapy, which uses heat or cold to remove
tissue, such as in the treatment of cardiac atrial fibrillation, or
removal of cancerous liver and kidney lesions, with greater
accuracy.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman">Vascular Imaging:
Our TAEUS technology enables ultrasound to view blood vessels from
any angle, using only a saline solution contrasting agent, unlike
Doppler ultrasound, which requires precise viewing angles. This
capability would enable the use of TAEUS-enhanced ultrasound to
easily identify arterial plaque or malformed vessels.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 24px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-size: 13px; font-family: Times New Roman">Tissue Perfusion:
Our TAEUS technology enables ultrasound to image blood flow at the
capillary level in a region, organ or tissue. This capability could
be used to assist physicians in characterizing microvasculature
fluid flows symptomatic of damaged tissue, such as internal
bleeding from trauma, or diseased tissue, such as certain
cancers.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: solid 2px #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: solid 2px #000000; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: solid 2px #000000; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">To
further test the capability of our TAEUS platform to distinguish
tissue composition in conjunction with an NAFLD application, we
engaged the Centre for Imaging Technology Commercialization
(&#x201C;CIMTEC&#x201D;), a contract research organization, to
initiate human studies. <font style="color: #000000">In October
2018, we received an Investigational Testing Authorization from
Health Canada to commence the first human studies with our TAEUS
clinical system targeting NAFLD, guiding our algorithm development,
and comparing our technology to MRI. The feasibility study, the
first of several planned human studies, is being conducted in
collaboration with Robarts Research Institute in London, Canada. We
reported our completion of this study on September 26, 2019. The
data collected from the study, including additional usability
inputs, was included in our TAEUS liver device technical file
submission for device CE Mark, which we submitted in December
2019.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ultrasound
systems are more broadly available to patients than either CT or
MRI systems. There are an estimated one million ultrasound systems
globally in use today generating over 400 million annual diagnostic
ultrasound procedures. Sales of ultrasound diagnostic equipment
were approximately $4.4 billion globally in 2017 and an estimated
30,000 to 50,000 new and replacement ultrasound systems are sold
into the market annually. Ultrasound systems are relatively
inexpensive compared to CT and MRI systems, with smaller portable
ultrasound systems costing as little as $10,000 and new cart-based
ultrasound systems costing between $75,000 and $200,000. These
numbers cover all types of diagnostic ultrasound procedures,
including systems intended for cardiology, prenatal and abdominal
use. However, we do not intend to address low-cost, portable
ultrasound systems and systems focused on applications, such as
prenatal care, where we believe our TAEUS technology will not
substantially impact patient care. Accordingly, we define our
addressable market for one or more of our TAEUS applications at
approximately 365,000 cart-based ultrasound systems currently in
use throughout the world.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Many
ultrasound systems are designed to be moved by an operator from
room to room, or closer to patients. CT and MRI systems are
stationary systems, requiring the patient to travel to a medical
center; there are only about 32,000 CT systems and 16,000 MRI
systems located in the United States. Ultrasound technology does
not present the same safety concerns as CT and MRI technology,
since ultrasound does not emit ionizing radiation and ultrasound
contrast agents are considered to be generally safe. The
ultrasound&#x2019;s imaging capabilities, however, are more limited
compared to CT and MRI technologies, which are able to measure
tissue temperature during thermal ablation surgery or quantify fat
to diagnose early stage liver disease.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">After
approval, our TAEUS technology can be added as an accessory to
existing ultrasound systems, helping to improve clinical
decision-making on the front lines of patient care, without
requiring new clinical workflows or large capital investments. We
are also developing TAEUS for incorporation into new ultrasound
systems, primarily through our collaboration with GE Healthcare,
described more fully below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Because
of the large number of traditional ultrasound systems currently in
global use, we are first developing our TAEUS technology for sale
as an aftermarket accessory that works with existing ultrasound
systems. Because our TAEUS technology is designed to enhance the
utility of, not replace, conventional ultrasound, we believe
healthcare providers will be able to increase the utilization of,
and generate new revenue from, their existing ultrasound systems
once we obtain required regulatory approval for specific
applications. Based on our design work and our understanding of the
ultrasound accessory market, we intend to price our initial NAFLD
TAEUS application at a price point approximating $50,000, which may
enable purchasers to recoup their investment by performing a
relatively small number of additional ultrasound procedures. We
further believe that clinicians will be attracted to our technology
because it will enable them to perform more procedures with
existing ultrasound equipment, thereby retaining more imaging
patients in their clinics rather than referring patients out to a
regional medical center for a CT or MRI scan.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Each of
our TAEUS platform applications will require regulatory approvals
before we are able to sell or license the application. Based on
certain factors, such as the installed base of ultrasound systems,
availability of other imaging technologies, such as CT and MRI,
economic strength and applicable regulatory requirements, we intend
to seek initial approval of our applications for sale in the
European Union, followed by the United States and
China.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
first TAEUS application we intend to commercialize is our NAFLD
TAEUS application. Our initial target market for this application
is the European Union. We believe that our NAFLD TAEUS application
will qualify for sale in the European Union as a Class IIa medical
device. As a result, we will be required to obtain a CE mark for
our NAFLD TAEUS application before we can sell the application in
the European Union. To this end, we have contracted with medical
device contract engineering firms to perform the commercial product
engineering for our NAFLD TAEUS application. Existing regulations
would not require us to conduct a clinical trial to obtain a CE
mark for this application. Nonetheless, for commercial reasons and
to support our CE mark application we have contracted CIMTEC to
conduct human studies to demonstrate our NAFLD TAEUS
application&#x2019;s ability to distinguish fat from lean tissue. In
December 2019, we submitted a <font style="color: #000000">technical file for a CE mark for our TAEUS liver
device.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">3</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">While
we are seeking a CE mark for our NAFLD TAEUS application, we are
also preparing to expand our sales, marketing and customer support
capabilities, so that we can commence initial sales of the
application in the European Union once we have received this
regulatory approval. Following receipt of such CE mark and
placement of initial systems with researchers and universities, we
plan to conduct one or more clinical studies to further demonstrate
this product&#x2019;s capabilities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Simultaneously
with the process of obtaining a CE mark for our NAFLD TAEUS
application, we intend to prepare for submission to the U.S. Food
and Drug Administration, or the FDA, an application under the Food,
Drug and Cosmetic Act, or the FD&amp;C Act, to sell our NAFLD TAEUS
application in the U.S. We anticipate that the application, as well
as those for our other TAEUS applications, will be submitted for
approval under Section 510(k) of the FD&amp;C Act. We expect that
our initial FDA clearance will allow us to sell the NAFLD TAEUS
application in the U.S. with general imaging claims. However, we
will need to obtain additional FDA clearances to be able to make
diagnostic claims for fatty tissue content determination.
Accordingly, to support our commercialization efforts we expect
that, following receipt of our initial FDA clearance, we will
submit one or more additional applications to the FDA, each of
which will need to include additional clinical trial data, so that
following receipt of the necessary clearances we may make those
diagnostic claims.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Collaboration with GE Healthcare</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
April 2016, we entered into a Collaborative Research Agreement with
General Electric Company, acting through its GE Healthcare business
unit and the GE Global Research Center, or GE Healthcare. Under the
terms of the agreement, GE Healthcare has agreed to assist us in
our efforts to commercialize our TAEUS technology for use in a
fatty liver application by, among other things, providing equipment
and technical advice, and facilitating introductions to GE
Healthcare clinical ultrasound customers. In return for this
assistance, we have agreed to afford GE Healthcare certain rights
of first offer with respect to manufacturing and licensing rights
for the target application. More specifically, we have agreed that,
prior to commercially releasing our NAFLD TAEUS application, we
will offer to negotiate an exclusive ultrasound manufacturer
relationship with GE Healthcare for a period of at least one year
of commercial sales. The commercial sales would involve, within our
sole discretion, either our Company commercially selling GE
Healthcare ultrasound systems as the exclusive ultrasound system
with our TAEUS fatty liver application embedded, or GE Healthcare
being the exclusive ultrasound manufacturer to sell ultrasound
systems with our TAEUS fatty liver application embedded. The
agreement is subject to termination by either party upon not less
than 60 days&#x2019; notice.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On
January 30, 2018, we and GE Healthcare entered into an amendment to
our agreement, extending its term by 21 months to January 22, 2020.
We are in discussions with GE Healthcare regarding further
extending this term.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Recent Developments</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Private Placement of Series A Preferred Stock, Common Stock and
Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 11, 2019, we closed the First Private Placement, in
which we sold 6,338.49 shares of its Series A Preferred Stock and
0.9 million shares of Common Stock, along with Series A Warrants
exercisable for an aggregate of 8.2 million shares of Common Stock,
to accredited investors (the &#x201C;Series A Investors&#x201D;) for
approximately $7.9 million of gross proceeds. The First Private
Placement was made pursuant to a Securities Purchase Agreement (the
&#x201C;Series A Purchase Agreement&#x201D;), dated as of December 5,
2019. The closing consisted of (i) the issuance of 5,809.09 shares
of Series A Preferred Stock, approximately 0.8 million shares of
Common Stock and Series A Warrants exercisable for an aggregate of
approximately 7.5 million shares of Common Stock to Series A
Investors party to the Series A Purchase Agreement as of December
5, 2019 and (ii) the issuance of 529.40 shares of Series A
Preferred Stock, approximately 0.1 million shares of Common Stock
and Series A Warrants exercisable for an aggregate of approximately
0.7 million shares of Common Stock to Investors who joined as
parties to the Series A Purchase Agreement as of December 10, 2019.
Pursuant to the Series A Purchase Agreement, each Investor elected
whether to receive shares of Series A Preferred Stock or shares of
Common Stock in the First Private Placement. We used a portion of
the net proceeds from the First Private Placement to repay certain
outstanding convertible notes due April 2020 and plan to use
remaining net proceeds for working capital and general corporate
purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
In connection with the closing of the First Private Placement, we
filed a Certificate of Designations of Series A Convertible
Preferred Stock (the &#x201C;Series A Certificate of
Designations&#x201D;) with the Secretary of State of the State of
Delaware setting forth the rights and preferences of the Series A
Preferred Stock. Each share of Series A Preferred Stock has a
$1,000 issue price (the &#x201C;Series A Issue Price&#x201D;).
Dividends accrue on the Series A Issue Price at a rate of 6.0% per
annum and are payable to holders of Series A Preferred Stock as,
when and if declared by our Board of Directors. Shares of Series A
Preferred Stock, including accrued but unpaid dividends, are
convertible into Common Stock at a conversion price of $0.87 per
share of Common Stock. The conversion price is subject to
proportional adjustment for certain transactions relating to our
capital stock, including stock splits, stock dividends and similar
transactions. Holders of Series A Preferred Stock are entitled to a
liquidation preference in the event of any liquidation, dissolution
or winding up of the Company based on their shares&#x2019; aggregate
Series A Issue Price and accrued and unpaid dividends. Holders may
convert their shares of Series A Preferred Stock into Common Stock
at any time and we have the right to cause each holder to convert
their shares of Series A Preferred Stock in the event that (i) the
average of the daily volume-weighted average price of Common Stock
over any 10 consecutive trading days is greater than $1.74 (as
adjusted for stock splits, stock dividends and similar
transactions) and (ii) there is then an effective registration
statement registering under the Securities Act of 1933, as amended
(the &#x201C;Securities Act&#x201D;), the resale of the shares of
Common Stock issuable upon such conversion of Series A Preferred
Stock (together, the &#x201C;Series A Forced Conversion
Conditions&#x201D;). Holders of shares of Series A Preferred Stock
vote with the holders of Common Stock and are entitled to a number
of votes equal to the number of shares of Common Stock into which
such holder&#x2019;s shares of Series A Preferred Stock are then
convertible.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">4</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Each Series A Warrant entitles the holder to purchase a share of
Common Stock for an exercise price per share equal to $0.87. The
Series A Warrants are exercisable commencing immediately upon
issuance and expire on the date five years after the date of the
closing of the First Private Placement (the &#x201C;Series A Closing
Date&#x201D;), unless earlier terminated pursuant to the terms of
the Series A Warrant. If, during the term of the Series A Warrants,
the Series A Forced Conversion Conditions are met, we may deliver
notice thereof to the holders of the Series A Warrants and, after a
30-day period following such notice, any unexercised Series A
Warrants will be forfeited. The Series A Warrants provide for
cashless exercise in the event there is no effective registration
statement registering under the Securities Act the resale of the
shares of Common Stock issuable upon exercise of such Series A
Warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000; font-size: 13px">
&#xA0;</font><font style="color: #000000">The Series A Purchase
Agreement includes customary representations, warranties and
covenants. In connection with the First Private Placement, we paid
to Lake Street, the placement agent, a commission of 8.0% of the
gross proceeds from the First Private Placement, agreed to
reimburse up to $35,000 of Lake Street&#x2019;s expenses and issued
to Lake Street a warrant exercisable for 327,606 shares of Common
Stock (the &#x201C;Series A Placement Agent Warrant&#x201D;). The
terms of the Series A Placement Agent Warrant are the same as those
of the Series A Warrants.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to the Series A Purchase Agreement, the Company, the
Investors and Lake Street entered into a registration rights
agreement (the &#x201C;Registration Rights Agreement&#x201D;)
pursuant to which we agreed to file a registration statement (the
&#x201C;Registration Statement&#x201D;) within 30 days of the Series
A Closing Date covering the resale of the shares of Common Stock
issuable upon conversion of the Series A Preferred Stock, the
shares of Common Stock issued at the closing of the First Private
Placement, and the shares of Common Stock issuable upon exercise of
the Series A Warrants and the Placement Agent Warrant
(collectively, the &#x201C;Series A Registrable Securities&#x201D;).
Pursuant to the Registration Rights Agreement, we have agreed to
use our commercially reasonable efforts to cause the Registration
Statement to become effective as soon as practicable after filing
and to remain effective until the earlier of the date that (i) all
of the Series A Registrable Securities have been sold or (ii) the
Series A Registrable Securities may be sold without restriction by
each holder pursuant to Rule 144 under the Securities
Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-style: italic; color: #000000; font-family: Times New Roman; font-size: 13px">
Private Placement of Series B Preferred Stock and
Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
On December 23, 2019, we closed the Second Private Placement, in
which we sold 351.711 shares of Series B Preferred Stock, along
with Series B Warrants exercisable for an aggregate of 426,316
shares of Common Stock, to accredited investors (the &#x201C;Series
B Investors&#x201D;) for approximately $405,000 of gross proceeds.
The Second Private Placement was made pursuant to a Securities
Purchase Agreement (the &#x201C;Series B Purchase Agreement&#x201D;),
dated as of December 19, 2019. We plan to use the net proceeds from
the Second Private Placement for working capital and general
corporate purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
In connection with the closing of the Second Private Placement, we
filed a Certificate of Designations of Series B Convertible
Preferred Stock (the &#x201C;Series B Certificate of
Designations&#x201D;) with the Secretary of State of the State of
Delaware setting forth the rights and preferences of the Series B
Preferred Stock. The Series B Preferred Stock has substantially the
same rights and preferences as Series A Preferred Stock, except for
a different conversion price and trading price of Common Stock at
which the Series B Preferred Stock becomes subject to automatic
conversion. Each share of Series B Preferred Stock has a $1,000
issue price (the &#x201C;Series B Issue Price&#x201D;). Dividends
accrue on the Series B Issue Price at a rate of 6.0% per annum and
are payable to holders of Series B Preferred Stock as, when and if
declared by our Board of Directors. Shares of Series B Preferred
Stock, including accrued but unpaid dividends, are convertible into
Common Stock at a conversion price of $0.99 per share of Common
Stock. The conversion price is subject to proportional adjustment
for certain transactions relating to our capital stock, including
stock splits, stock dividends and similar transactions. Holders of
Series B Preferred Stock are entitled to a liquidation preference
in the event of any liquidation, dissolution or winding up of the
Company based on their shares&#x2019; aggregate Series B Issue Price
and accrued and unpaid dividends. Such liquidation preference of
Series B Preferred Stock holders is on a</font> <font style="font-style: italic; color: #000000">pari passu</font> <font style="color: #000000">basis with holders of Series A Preferred Stock.
Holders may convert their shares of Series B Preferred Stock into
Common Stock at any time and we have the right to cause each holder
to convert their shares of Series B Preferred Stock in the event
that (i) the average of the daily volume-weighted average price of
Common Stock over any 10 consecutive trading days is greater than
$1.98 (as adjusted for stock splits, stock dividends and similar
transactions) and (ii) there is then an effective registration
statement registering under the Securities Act the resale of the
shares of Common Stock issuable upon such conversion of Series B
Preferred Stock (together, the &#x201C;Series B Forced Conversion
Conditions&#x201D;). Holders of shares of Series B Preferred Stock
vote with the holders of Common Stock, and with any other shares of
preferred stock that vote with the Common Stock, and are entitled
to a number of votes equal to the number of shares of Common Stock
into which such holder&#x2019;s shares of Series B Preferred Stock
are then convertible.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Each Series B Warrant entitles the holder to purchase shares of
Common Stock for an exercise price per share equal to $0.99. The
Series B Warrants are exercisable commencing immediately upon
issuance and expire on the date five years after the date of the
closing of the Second Private Placement (the &#x201C;Series B
Closing Date&#x201D;), unless earlier terminated pursuant to the
terms of the Series B Warrant. If, during the term of the Series B
Warrants, the Series B Forced Conversion Conditions are met, we may
deliver notice thereof to the holders of the Series B Warrants and,
after a 30-day period following such notice, any unexercised Series
B Warrants will be forfeited. The Series B Warrants provide for
cashless exercise in the event there is no effective registration
statement registering under the Securities Act the resale of the
shares of Common Stock issuable upon exercise of such Series B
Warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Series B Purchase Agreement includes customary representations,
warranties and covenants. In connection with the closing of the
Second Private Placement, we paid to Lake Street, the placement
agent, a commission of approximately 8.0% of the gross proceeds
from the Second Private Placement and issued to Lake Street a
warrant exercisable for 14,211 shares of Common Stock (the
&#x201C;Series B Placement Agent Warrant&#x201D;). The terms of the
Series B Placement Agent Warrant are the same as those of the
Series B Warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">5</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="color: #000000; font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-top: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Pursuant to the Series B Purchase Agreement, the Series B Investors
became parties to the Registration Rights Agreement, pursuant to
which we agreed to file the Registration Statement within 30 days
of the Series A Closing Date covering the resale of the shares of
Common Stock issuable upon conversion of the Series B Preferred
Stock, the shares of Common Stock issuable upon exercise of the
Series B Warrants and the Series B Placement Agent Warrant and the
Series A Registrable Securities. The Registration Rights Agreement
is summarized above in this &#x201C;Recent Developments&#x201D;
section.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Risks Related to Our Business</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">An
investment in our Securities involves a high degree of risk. You
should carefully consider the risks summarized below. These risks
are discussed more fully in the &#x201C;Risk Factors&#x201D; section
of our Form 10-K incorporated herein by reference. These risks
include, but are not limited to, the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">We have a history
of operating losses, and we may never achieve or maintain
profitability.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">Our efforts may
never result in the successful development of commercial
applications based on our TAEUS technology.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">If we fail to
obtain and maintain necessary regulatory clearances or approvals
for our TAEUS applications, or if clearances or approvals for
future applications and indications are delayed or not issued, our
commercial operations will be harmed.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">Our limited
commercial experience makes it difficult to evaluate our current
business, predict our future results or forecast our financial
performance and growth.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">We are depending on
third parties to design, manufacture and seek regulatory approval
of our TAEUS applications. If any third party fails to successfully
design, manufacture and gain regulatory approval of our TAEUS
applications, our business will be materially harmed.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">Competition in the
medical imaging market is intense and we may be unable to
successfully compete.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">If we are unable to
secure additional financing on favorable terms, or at all, to meet
our future capital needs, we will be unable to complete fully our
current business plan.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">We intend to market
our TAEUS applications, if approved, globally, in which case we
will be subject to the risks of doing business outside of the
United States.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; text-indent: 0px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">If we are unable to
protect our intellectual property, then our financial condition,
results of operations and the value of our technology and products
could be adversely affected.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Implications of Being an Emerging Growth Company</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
an &#x201C;emerging growth company,&#x201D; as defined in the
Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS
Act&#x201D;) and, for as long as we continue to be an
&#x201C;emerging growth company,&#x201D; we may choose to take
advantage of exemptions from various reporting requirements
applicable to other public companies but not to &#x201C;emerging
growth companies,&#x201D; including, but not limited to, not being
required to comply with the auditor attestation requirements of
Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure
obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not
previously approved. We could be an &#x201C;emerging growth
company&#x201D; until December 31, 2022, or until the earliest of
(i) the last day of the first fiscal year in which our annual gross
revenues exceed $1.07 billion, (ii) the date that we become a
&#x201C;large accelerated filer&#x201D; as defined in Rule 12b-2
under the Securities Exchange Act of 1934, as amended (the
&#x201C;Exchange Act&#x201D;), which would occur if the market value
of our common stock that is held by non-affiliates exceeds $700
million as of the last business day of our most recently completed
second fiscal quarter, or (iii) the date on which we have issued
more than $1 billion in non-convertible debt during the preceding
three-year period. We are choosing to &#x201C;opt out&#x201D; of the
extended transition periods available under the JOBS Act for
complying with new or revised accounting standards, but intend to
take advantage of the other exemptions discussed
above.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We are
also currently considered a &#x201C;smaller reporting
company,&#x201D; which generally means that we have a public float
of less than $250 million. If we are still considered a
&#x201C;smaller reporting company&#x201D; at such time as we cease to
be an &#x201C;emerging growth company,&#x201D; we will be subject to
increased disclosure requirements. However, the disclosure
requirements will still be less than they would be if we were not
considered either an &#x201C;emerging growth company&#x201D; or a
&#x201C;smaller reporting company.&#x201D; Specifically, similar to
&#x201C;emerging growth companies,&#x201D; &#x201C;smaller reporting
companies&#x201D; are able to provide simplified executive
compensation disclosures in their filings; are exempt from the
provisions of Section 404(b) of the Sarbanes-Oxley Act requiring
that independent registered public accounting firms provide an
attestation report on the effectiveness of internal control over
financial reporting; and have certain other decreased disclosure
obligations in their SEC filings, including, among other things,
being required to provide only two years of audited financial
statements in annual reports.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Corporate Information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We were
incorporated in Delaware in July 2007 and have a wholly-owned
subsidiary, ENDRA Life Sciences Canada Inc. Our corporate
headquarters is located at 3600 Green Court, Suite 350, Ann Arbor,
Michigan 48105-1570. Our website can be accessed at
www.endrainc.com. The telephone number of our principal executive
office is (734) 335-0468. The information contained on, or that may
be obtained from, our website is not, and shall not be deemed to
be, a part of this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
&#xA0;&#xA0; <font style="font-family: Times New Roman; font-size: 13px"><br></font></div>
</td>
<td style="vertical-align: top; width: 1%; border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 98%; border-bottom: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">6</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
THE OFFERING</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; width: 100%; font-family: Times New Roman; font-size: 13px; margin: 0px auto 0px 0px;">
<tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Common
Stock currently outstanding</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8,420,401
<font style="font-size: 70%; vertical-align: top">(1)</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Common
Stock offered by the Company</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">None.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Common
Stock offered by the Selling Stockholders</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Up to
25,644,002 shares of Common Stock, which include:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">904,526 shares
issued in the First Private Placement;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">7,191,873 shares
that are issuable upon conversion of the Series A Preferred
Stock;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">8,096,399 shares
that are issuable upon exercise of the Series A
Warrants;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">an estimated
8,660,410 shares that may be issuable in respect of accrued and
unpaid dividends on shares of Series A Preferred
Stock;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">232,461 shares that
are issuable upon conversion of the Series B Preferred
Stock;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">278,948 shares that
are issuable upon exercise of the Series B Warrants;
and</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; text-indent: 24px"><font style="font-size: 13px">&#x25CF;</font><font id="tab2" style="letter-spacing: 12px; color: black">&#xA0;</font><font style="font-family: Times New Roman; font-size: 13px">an estimated
279,385 shares that may be issuable in respect of accrued and
unpaid dividends on shares of Series B Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Use of
proceeds</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We will
not receive any of the proceeds from the sales of the Securities by
the Selling Stockholders, although we will receive proceeds from
the exercise price of any Series A Warrants and Series B Warrants
exercised on a cash basis. We intend to use those proceeds, if any,
for working capital and general corporate purposes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Nasdaq
symbol for Common Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">NDRA.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 40%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Risk
factors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="width: 1%;">
<div><font>&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 59%;">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">You
should carefully consider the information set forth in this
prospectus and, in particular, the specific factors set forth in
the &#x201C;Risk Factors&#x201D; section in the Form 10-K
incorporated herein by reference before deciding whether or not to
invest in the Securities.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: -24px">
<font style="font-family: Times New Roman; font-size: 13px">(1) As
of December 31, 2019. This number excludes the shares of Common
Stock issuable upon the conversion of the Series A Preferred Stock
and Series B Preferred Stock, shares of Common Stock issuable upon
exercise of the Series A Warrants and Series B Warrants, and shares
of Common Stock that may be issuable in respect of accrued and
unpaid dividends on shares of Series A Preferred Stock and Series B
Preferred Stock covered hereby as well as:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">1,932,000 shares of
Common Stock issuable upon the exercise of outstanding warrants
issued in our initial public offering listed on the Nasdaq Capital
Market under the symbol &#x201C;NDRAW,&#x201D; at an exercise price
of $6.25 per share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">2,606,566 shares of
Common Stock issuable upon the exercise of outstanding unregistered
warrants, at a weighted average exercise price of $2.83 per
share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">3,413,723 shares of
Common Stock issuable upon the exercise of outstanding stock
options issued pursuant to our 2016 Omnibus Incentive Plan (the
&#x201C;Incentive Plan&#x201D;) at a weighted average exercise price
of $1.80 per share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">1,109,532 shares of
Common Stock reserved for future issuance under our Incentive Plan;
and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">371,517 shares of
Common Stock issuable upon the conversion our 10.0% Senior Secured
Convertible Notes due April 26, 2020, including an estimated 6,426
shares that may be issued in respect of accrued and unpaid interest
upon conversion of such notes.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">See
&#x201C;Description of Capital Stock&#x201D; below.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">7</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
RISK FACTORS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">An
investment in the Securities involves a high degree of risk. You
should carefully consider all of the information set forth in this
prospectus and the documents incorporated by reference herein and,
in particular, the risks set forth under the section captioned
&#x201C;Risk Factors&#x201D; contained in our Form 10-K, before
deciding to invest in the Securities. The risks and uncertainties
we have described this prospectus and in any document incorporated
herein are not the only ones we face, but are considered to be the
most material.<font style="color: #000000">&#xA0;</font>If
additional risks and uncertainties that are not presently known to
us or that we currently deem immaterial later materialize, then our
business, prospects, results of operations and financial condition
could be materially adversely affected. In that event, the trading
price of our securities could decline, and you may lose all or part
of your investment in our securities.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">8</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus and the documents incorporated by reference contain
&#x201C;forward-looking statements&#x201D; within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange
Act, that are intended to be covered by the &#x201C;safe
harbor&#x201D; created by those sections. Forward-looking
statements, which are based on certain assumptions and describe our
future plans, strategies and expectations, can generally be
identified by the use of forward-looking terms such as
&#x201C;believe,&#x201D; &#x201C;expect,&#x201D; &#x201C;may,&#x201D;
&#x201C;will,&#x201D; &#x201C;should,&#x201D; &#x201C;would,&#x201D;
&#x201C;could,&#x201D; &#x201C;seek,&#x201D; &#x201C;intend,&#x201D;
&#x201C;plan,&#x201D; &#x201C;goal,&#x201D; &#x201C;project,&#x201D;
&#x201C;estimate,&#x201D; &#x201C;anticipate,&#x201D;
&#x201C;strategy&#x201D;, &#x201C;future&#x201D;, &#x201C;likely&#x201D;
or other comparable terms and references to future periods. All
statements other than statements of historical facts included in
this prospectus and the documents incorporated by reference
regarding our strategies, prospects, financial condition,
operations, costs, plans and objectives are forward-looking
statements. Examples of forward-looking statements include, among
others, statements we make regarding expectations for revenues,
cash flows and financial performance, the anticipated results of
our development efforts and the timing for receipt of required
regulatory approvals and product launches.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Forward-looking
statements are neither historical facts nor assurances of future
performance. Instead, they are based only on our current beliefs,
expectations and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and
trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ
materially from those indicated in the forward-looking statements.
Therefore, you should not rely on any of these forward-looking
statements. Important factors that could cause our actual results
and financial condition to differ materially from those indicated
in the forward-looking statements include, among others, the
following:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our limited
commercial experience, limited cash and history of
losses;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
obtain adequate financing to fund our business operations in the
future;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
achieve profitability;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
develop a commercially feasible application based on our TAEUS
technology;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">market acceptance
of our technology;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">results of our
human studies, which may be negative or inconclusive;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to find
and maintain development partners;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our reliance on
collaborations and strategic alliances and licensing
arrangements;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">the amount and
nature of competition in our industry;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
protect our intellectual property;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">potential changes
in the healthcare industry or third-party reimbursement
practices;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">delays and changes
in regulatory requirements, policy and guidelines including
potential delays in submitting required regulatory applications for
CE mark certification or FDA approval;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
obtain CE mark certification and secure required FDA and other
governmental approvals for our TAEUS applications;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
maintain compliance with Nasdaq listing standards;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our ability to
comply with regulation by various federal, state, local and foreign
governmental agencies and to maintain necessary regulatory
clearances or approvals; and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">the other risks and
uncertainties described in the Risk Factors section of our Form
10-K and in the Management&#x2019;s Discussion and Analysis of
Financial Condition and Results of Operations section in our
Quarterly Report on Form 10-Q for the quarterly period ended
September 30, 2019.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
forward-looking statement made by us in this prospectus is based
only on information currently available to us and speaks only as of
the date on which it is made. We undertake no obligation to
publicly update any forward-looking statement, whether written or
oral, that may be made from time to time, whether as a result of
new information, future developments or otherwise. We anticipate
that subsequent events and developments will cause our views to
change. You should read this prospectus and the documents
referenced in this prospectus and filed as exhibits to the
registration statement, of which this prospectus is a part,
completely and with the understanding that our actual future
results may be materially different from what we expect. Our
forward-looking statements do not reflect the potential impact of
any future acquisitions, merger, dispositions, joint ventures or
investments we may undertake. We qualify all of our forward-looking
statements by these cautionary statements.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">9</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
USE OF PROCEEDS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We will
not receive any proceeds from the sale of Common Stock by the
Selling Stockholders. To the extent we receive proceeds from the
exercise of Series A Warrants and Series B Warrants held by the
Selling Stockholders, we will use those proceeds for working
capital and other general corporate purposes.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
agreed to bear the expenses (other than selling commissions or any
legal expenses incurred by any Selling Stockholder) in connection
with the registration of the shares of our Common Stock being
offered for resale hereunder by the Selling
Stockholders.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">See
&#x201C;Plan of Distribution&#x201D; elsewhere in this prospectus for
more information.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
DETERMINATION OF OFFERING PRICE</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders will determine at what price they may sell the
offered Common Stock, and such sales may be made at prevailing
market prices or at privately negotiated prices. See &#x201C;Plan of
Distribution&#x201D; below for more information.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">10</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SELLING STOCKHOLDERS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus covers the resale from time to time by the Selling
Stockholders identified in the table below of up to 25,644,002
shares of Common Stock, which include:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">904,526 shares
issued in the First Private Placement;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">7,191,873 shares
that are issuable upon conversion of the Series A Preferred
Stock;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">8,096,399 shares
that are issuable upon exercise of the Series A
Warrants;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">an estimated
8,660,410 shares that may be issuable in respect of accrued and
unpaid dividends on shares of Series A Preferred
Stock;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">232,461 shares that
are issuable upon conversion of the Series B Preferred
Stock;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">278,948 shares that
are issuable upon exercise of the Series B Warrants;
and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 48px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">an estimated
279,385 shares that may be issuable in respect of accrued and
unpaid dividends on shares of Series A Preferred Stock</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders identified in the table below may from time to
time offer and sell under this prospectus any or all of the shares
of Common Stock covered hereby described under the column
&#x201C;Shares of Common Stock Registered Hereby&#x201D; in such
table below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certain
Selling Stockholders may be deemed to be &#x201C;underwriters&#x201D;
as defined in the Securities Act. Any profits realized by such
Selling Stockholders may be deemed to be underwriting discounts and
commissions under the Securities Act.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
table below has been prepared based upon the information furnished
to us by the Selling Stockholders and/or our transfer agent as of
the date of this prospectus. The Selling Stockholders identified
below may have converted, sold, transferred or otherwise disposed
of some or all of their Series A Preferred Stock, Series A
Warrants, Series B Preferred Stock, Series B Warrants or underlying
Common Stock since the date on which the information in the
following table is presented in transactions exempt from or not
subject to the registration requirements of the Securities Act.
Information concerning the Selling Stockholders may change from
time to time and, if necessary, we will amend or supplement this
prospectus accordingly. We cannot give an estimate as to the number
of shares of Common Stock that will actually be held by the Selling
Stockholders upon termination of this offering because the Selling
Stockholders may offer some or all of their Common Stock, as
applicable, under the offering contemplated by this prospectus or
may acquire additional shares of Common Stock. The aggregate total
number of shares of Common Stock that may be sold hereunder will
not exceed the number of shares of Common Stock offered hereby.
Please read the section entitled &#x201C;Plan of Distribution&#x201D;
in this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following table sets forth the name of each Selling Stockholder,
the number of shares of our Common Stock beneficially owned by such
Selling Stockholder before this offering, the number of shares of
Common Stock to be offered for such Selling Stockholder&#x2019;s
account and (if one percent or more) the percentage of Common Stock
to be beneficially owned by such Selling Stockholder after
completion of the offering. The number of shares of Common Stock
owned are those beneficially owned, as determined under the rules
of the SEC, and such information is not necessarily indicative of
beneficial ownership for any other purpose. Under such rules, the
Selling Stockholders&#x2019; beneficial ownership includes any
shares of our Common Stock as to which a person has sole or shared
voting power or dispositive power and any shares of Common Stock
which the person has the right to acquire within 60 days after
December 31, 2019 (as used in this section, the
&#x201C;Determination Date&#x201D;), through the conversion or
exercise of any option, warrant or right or other security
(including upon the conversion of the Series A Preferred Stock and
Series B Preferred Stock and exercise of the Series A Warrants and
Series B Warrants), or pursuant to the automatic termination of a
power of attorney or revocation of a trust, discretionary account
or similar arrangement, and such shares are deemed to be
beneficially owned and outstanding for computing the share
ownership and percentage of the person holding such options,
warrants or other rights, but are not deemed outstanding for
computing the percentage of any other person. Except where we had
knowledge of such ownership, the number presented in this column
may not include shares held in street name or through other
entities over which the Selling Stockholders have voting and
dispositive power.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unless
otherwise set forth below, based upon information furnished to us
by the Selling Stockholders, (a) the persons and entities named in
the table have sole voting and sole dispositive power with respect
to the shares set forth opposite the Selling Stockholder&#x2019;s
name, subject to community property laws, where applicable, (b) no
Selling Stockholder had any position, office or other material
relationship within the past three years with us or with any of our
predecessors or affiliates, and (c) no Selling Stockholder is a
broker-dealer or an affiliate of a broker-dealer. The number of
shares of Common Stock shown as beneficially owned before the
offering is based on information furnished to us or otherwise based
on information available to us at the timing of the filing of the
registration statement of which this prospectus forms a
part.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">11</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:52%;">
<div style="text-align: center; text-indent: 0px; margin-right: 0px; margin-left: 0px; border-bottom: 2px solid rgb(0, 0, 0);"><font style="font-size: 11px"><font style="font-weight: bold; font-family: Times New Roman;">Name of Selling
Security Holder</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px"><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Shares of Common
Stock Beneficially Owned Prior to this Offering</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px"><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Shares of Common
Stock Registered Hereby</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px"><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Shares of Common
Stock Beneficially Owned upon Completion of this Offering
(1)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="font-size: 11px"><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 2px #000000;display:inline-block;">
<div><font style="font-weight: bold; font-family: Times New Roman;">Percentage of
Common Stock Beneficially Owned upon Completion of this Offering
(2)</font></div>
</font><font style="text-align: left; padding-bottom:2px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Anthony
DiGiandomenico (3)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391,058</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">201,006</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">190,049</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2.3</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Dennis T. Whalen
&amp; Linda P. Whalen JTWROS (4)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Xavier Aguirre
(5)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,102</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Carlo Alberici
(6)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">147,450</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">236,229</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James R. Aldridge
(7)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Howard Altshuler
(8)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">51,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">11,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Patrick M.
Barberich &amp; Monica Barberich JTWROS (9)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Anthony J. Berni
(10)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Chase Lankford Bice
(11)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Mark W. Boyer
(12)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">194,396</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">311,441</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jeffrey Ronald
Boyle (13)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">37,558</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">60,171</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John M. Brady
(14)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael J. Burwell
(15)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">194,396</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">311,441</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Matthew W. Cambi
(16)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Donald Cameron
(17)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Timothy L.
Carpenter &amp; Julie L. Carpenter JTWROS (18)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Peter A. Casey
(19)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,102</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Catalytic
Opportunity LLC Series A (20)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,010,052</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,220,301</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Catalytic
Opportunity LLC Series A-1 (21)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">2,512,564</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">4,025,375</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Vaidyanthan
Chandrashekhar (22)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Rich Chirico
(23)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Ronald J. Ciasulli
(24)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">56,336</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">90,256</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Mario Dell'Aera
(25)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">244,646</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391,947</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Mark R. Demich
(26)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Paul G. Elie
(27)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael Fahey
(28)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Charles Joseph Finn
(29)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">147,450</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">236,229</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gregory G. Galdi
(30)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">288,288</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">461,866</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Philip Garland
&amp; Cynthia Garland JTWROS (31)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Scott J. Gehsman
(32)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">TTEE Patrick John
Gregory Revocable Trust DTD 6-26-1990 (33)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">67,048</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">107,417</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Scott Guasta
(34)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael Harsh &amp;
Sandra E. Hansen Harsh JTWROS (35)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">56,044</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">35,425</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">33,932</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Kevin A. Healy
(36)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Kevin J. Herzberg
(37)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Dennis D. Howarter
&amp; Pamela J. Howarter JTWROS (38)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">194,396</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">311,441</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Donald L. Hulet
(39)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">67,708</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">108,475</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Frank Ingriselli
(40)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Joseph M. Janinski
(41)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Anthony D. Johnston
(42)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Robert
Kastenschmidt (43)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Robert Richard
Keehan (44)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Frederick M. Kelso
(45)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Benjamin King
(46)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John Klinge
(47)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James M. Koch
(48)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">70,352</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">112,711</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James P. Kolar
(49)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John C. Koppin
(50)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Kurtis Krentz
(51)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">144,144</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">230,933</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jeffrey E. Kuhlin
(52)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Dennis Lam
(53)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James C. Leslie
(54)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Paul E. Linthorst
(55)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jose M. Martinez
(56)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">William E. Marx
(57)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Thorne Joseph Brown
Matteson (58)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Joseph Michalczyk
(59)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,758</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">124,576</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Francois Michelon
(60)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">450,811</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">16,104</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">440,759</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">5.2</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">%</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jeffery L. Miller
&amp; Khristen N. Zar JTWROS (61)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Russell Moore
(62)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jorge Morazzani
(63)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Edmond Allen
Morrison (64)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Chester P. Mowrey,
Jr. (65)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James Eric Nicely
&amp; Karen B. Nicely JTWROS (66)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael P. Niland
&amp; Jill Kathleen Niland JTWROS (67)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">David B. O'Neill
(68)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">147,450</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">236,229</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jonathan Padnos
(69)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">201,006</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">201,006</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Alan W. Page
(70)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">87,148</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">139,620</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael A. Page
(71)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Alexandre N. Palma
(72)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">87,148</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">139,620</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">David Petterson
(73)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">164,244</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">263,136</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Laurence M. Pfeffer
(74)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John D. Potter
(75)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael P.
Quackenbush Jr. (76)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Peter D. Raymond
(77)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Erick E. Richardson
(78)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">502,514</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">805,077</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Juan R. Rivero
(79)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Thomas Michael
Rooney (80)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Maj-Britt Rosenbaum
(81)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Scott Joseph
Schueller (82)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Donald P. Sesterhen
(83)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Steven J. Shanker
Living Trust DTD 4-9-1997 (84)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">147,450</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">236,229</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Kevin P. Smithson
(85)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael Snow
(86)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James Somers
(87)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">164,244</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">263,136</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John Richard Stamm
(88)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gary Sterbinsky
(89)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">37,558</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">60,171</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James Douglas Summa
(90)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Ramesh Telang
(91)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Oscar Teunissen
(92)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gary and Deborah
Tillett Revocable Trust DTD 8-10-2012 (93)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Amaresh Tripathy
(94)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Chetan R. Vagholkar
(95)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Gerard J. Verweij
(96)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">67,048</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">107,417</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Timothy S. Vitale
(97)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Craig Watchmaker
(98)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jonathan Richard
Worden (99)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,102</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Mohibullah
Yousufani (100)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jeffrey
E. Zaleski (101)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Simon
Mawson (102)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Mike
Ruffer (103)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">70,352</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">112,711</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Dennis
Scullin (104)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">48,247</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">74,605</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Jon
E. Schmidt (105)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">173,685</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">268,569</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Daniel
Goodman (106)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">48,247</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">74,605</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Eric
Samuelson (107)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">192,983</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">298,410</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">The
Crudup Family Trust (108)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">48,247</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">74,605</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">*</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jonathan E.
Ansbacher (109)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Joseph C. Atkinson
(110)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Keith Belote
(111)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">37,558</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">60,171</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Kevin M. Borkowski
(112)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">20,102</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Mark R
Busch/Valerie Y Busch JTWROS (113)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">8,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Dennis L. Chesley
(114)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Charles Christensen
(115)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">147,450</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">236,229</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Michael L.
Desautels Account 2 (116)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Daniel DiFilippo
(117)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Emilio DiMatteo
&amp; Jessica DiMatteo JTWROS (118)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Miles E. Everson
(119)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">James M. Fiscus
(120)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">David A. Fitz
(121)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Paul P. Frank III
&amp; Colleen B. Frank Joint Tenants by Entirety (122)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">David J. Gilbertson
(123)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Brian W. Hannan
(124)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Keith Jackson
(125)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">194,396</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">311,441</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Donald Kendall
(126)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">244,646</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">391,947</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Samir Mammadov
(127)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Benjamin L. Padnos
(128)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">502,514</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">502,514</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Daniel P. Padnos
(129)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jeffrey and
Margaret Padnos (130)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">301,508</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">301,508</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jeffrey Padnos
&amp; Margaret Padnos 2010 Generation Trust (131)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">502,514</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">502,514</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Rich Shappard
(132)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Jaivardhan Sinha
(133)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Harold Wayne Smith
Jr. (134)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">John W. Stadtler
(135)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">144,144</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">230,933</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Pierre Alain
Nicholas P Sur (136)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">77,098</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">123,518</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Robert B. Taylor
(137)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Ravjiv A. Thadani
(138)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">87,148</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">139,620</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Laurie
A. Vanraemdonck Trust DTD 4-7-2008 (139)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stephen
V. Zawoyski (140)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">46,948</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,215</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">David
R. Wells (141)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">99,786</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">32,205</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">79,684</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Kim
E. Tobler (142)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Marc
D. Silverman &amp; Mitra Best Silverman JTWROS (143)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Henry
A. Padinha &amp; Terri A. Padinha JT COMM PROP (144)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">30,152</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">48,306</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Chad
F. Mueller (145)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">100,504</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">161,017</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Adan
Martinez (146)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">40,202</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">64,407</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Scott
M. Curran (147)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Allan
Michael Baccala (148)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,252</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">80,509</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:52%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Ballington
Living Trust DTD 8-5-14 (149)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">97,198</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">155,721</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">-</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">*</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 24px"><font style="font-family: Times New Roman; font-size: 13px">*&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Less than
1%</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(1)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Assumes all of the
shares of Common Stock registered on the registration statement of
which this prospectus is a part are sold in the offering, that
shares of Common Stock beneficially owned by the Selling
Stockholders but not being offered pursuant to this prospectus (if
any) are not sold, and that no additional shares of Common Stock
are purchased or otherwise acquired by the Selling
Stockholders.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">12</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Percentages are
based on the 8,420,401 shares of Common Stock issued and
outstanding as of the Determination Date. Shares of our Common
Stock subject to options, warrants or conversion rights that are
currently exercisable or convertible, or exercisable or convertible
within 60 days of the Determination Date, are deemed to be
outstanding for the purpose of computing the percentage ownership
of the person holding those options, warrants or conversion rights,
but are not treated as outstanding for the purpose of computing the
percentage ownership of any other person.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(3)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock held prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issued in the First Private Placement and issuable upon
exercise of Series A Warrants. Shares of Common Stock registered
hereby include (i) 100,503 shares of Common Stock issued in the
First Private Placement and (ii) 100,503 shares of Common Stock
issuable upon the exercise of Series A Warrants. Mr. DiGiandomenico
has served on our Board of Directors since 2013.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(4)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(5)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 10,051 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 10,051 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 12,103 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(6)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 73,725 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 73,725 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 88,779 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(7)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(8)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock held prior to the First Private Placement, issuable
upon the conversion of Series A Preferred Stock and issuable upon
exercise of Series A Warrants and shares of Common Stock. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(9)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(10)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(11)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii)15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">13</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(12)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 97,198 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 97,198 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 117,045 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(13)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 18,779 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 18,779 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 22,613 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(14)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(15)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 97,198 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 97,198 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 117,045 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(16)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(17)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(18)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(19)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 10,051 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 10,051 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 12,103 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(20)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 1,005,026 shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock, (ii) 1,005,026 shares of Common Stock issuable upon the
exercise of Series A Warrants and (iii) an estimated 1,210,249
shares of Common Stock that may be issuable in respect of accrued
but unpaid dividends on shares of Series A Preferred Stock. Joseph
Giamichael holds sole voting and dispositive power over these
shares.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(21)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 1,256,282 shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock, (ii) 1,256,282 shares of Common Stock issuable upon the
exercise of Series A Warrants and (iii) an estimated 1,512,811
shares of Common Stock that may be issuable in respect of accrued
but unpaid dividends on shares of Series A Preferred Stock. Joseph
Giamichael holds sole voting and dispositive power over these
shares.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">14</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(22)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(23)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(24)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 28,168 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 28,168 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 33,920 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(25)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 122,323 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 122,323 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 147,301 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(26)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(27)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(28)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(29)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 73,725 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 73,725 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 88,779 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(30)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 144,144 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 144,144 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 173,578 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(31)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">15</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(32)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(33)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 33,524 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 33,524 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 40,369 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(34)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 50,252 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 50,252 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 60,513 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(35)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement and shares
issuable upon exercise of stock options beneficially owned by Mr.
Harsh and shares issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 11,056 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 11,056 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 13,313 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock. Mr. Harsh has
served on our Board of Directors since 2015.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(36)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(37)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(38)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 97,198 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 97,198 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 117,045 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(39)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 33,854 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 33,854 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 40,767 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(40)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(41)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">16</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(42)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(43)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(44)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(45)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(46)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 25,126 shares of Common Stock issued
in the First Private Placement and (ii) 25,126 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(47)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(48)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 35,176 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 35,176 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 42,359 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(49)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(50)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(51)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 72,072 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 72,072 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 86,789 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(52)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">17</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(53)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(54)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(55)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(56)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(57)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(58)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(59)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,879 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,879 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,818 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(60)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 5,026 shares of Common Stock issuable
upon the conversion of Series A Preferred Stock, (ii) 5,026 shares
of Common Stock issuable upon the exercise of Series A Warrants and
(iii) an estimated 6,052 shares of Common Stock that may be
issuable in respect of accrued but unpaid dividends on shares of
Series A Preferred Stock. Mr. Michelon has served as our Chief
Executive Officer and Chairman of our Board of Directors since
2015.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(61)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(62)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">18</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(63)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(64)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(65)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(66)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(67)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,216 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(68)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 73,725 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 73,725 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 88,779 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(69)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 100,503 shares of Common Stock issued
in the First Private Placement and (ii) 100,503 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(70)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 43,574 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 43,574 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 52,472 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(71)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(72)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 43,574 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 43,574 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 52,472 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">19</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(73)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 82,122 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 82,122 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 98,892 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(74)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(75)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(76)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(77)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(78)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 251,257 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 251,257 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 302,563 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(79)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(80)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(81)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(82)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">20</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(83)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(84)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 73,725 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 73,725 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 88,779 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(85)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(86)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(87)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 82,122 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 82,122 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 98,892 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(88)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(89)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 18,779 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 18,779 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 22,613 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(90)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(91)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(92)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 50,252 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 50,252 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 60,513 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">21</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(93)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(94)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(95)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(96)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 33,524 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 33,524 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 40,369 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(97)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 20,101 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 20,101 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 24,205 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(98)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(99)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 10,051 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 10,051 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 12,103 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(100)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(101)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(102)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 50,252 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 50,252 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 60,513 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">22</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(103)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 35,176 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 35,176 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 42,359 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(104)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series B Preferred
Stock and issuable upon exercise of Series B Warrants. Shares of
Common Stock registered hereby include (i) 21,931 shares of Common
Stock issuable upon the conversion of Series B Preferred Stock,
(ii) 26,316 shares of Common Stock issuable upon the exercise of
Series B Warrants and (iii) an estimated 26,358 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series B Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(105)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series B Preferred
Stock and issuable upon exercise of Series B Warrants. Shares of
Common Stock registered hereby include (i) 78,948 shares of Common
Stock issuable upon the conversion of Series B Preferred Stock,
(ii) 94,737 shares of Common Stock issuable upon the exercise of
Series B Warrants and (iii) an estimated 94,884 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series B Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(106)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series B Preferred
Stock and issuable upon exercise of Series B Warrants. Shares of
Common Stock registered hereby include (i) 21,931 shares of Common
Stock issuable upon the conversion of Series B Preferred Stock,
(ii) 26,316 shares of Common Stock issuable upon the exercise of
Series B Warrants and (iii) an estimated 26,358 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series B Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(107)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series B Preferred
Stock and issuable upon exercise of Series B Warrants. Shares of
Common Stock registered hereby include (i) 87,720 shares of Common
Stock issuable upon the conversion of Series B Preferred Stock,
(ii) 105,263 shares of Common Stock issuable upon the exercise of
Series B Warrants and (iii) an estimated 105,427 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series B Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(108)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series B Preferred
Stock and issuable upon exercise of Series B Warrants. Shares of
Common Stock registered hereby include (i) 21,931 shares of Common
Stock issuable upon the conversion of Series B Preferred Stock,
(ii) 26,316 shares of Common Stock issuable upon the exercise of
Series B Warrants and (iii) an estimated 26,358 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series B Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(109)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(110)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(111)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 18,779 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 18,779 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 22,613 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(112)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 10,051 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 10,051 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 12,103 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">23</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(113)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock and publicly traded warrants held prior to the First
Private Placement, shares of Common Stock issuable upon the
conversion of Series A Preferred Stock and issuable upon exercise
of Series A Warrants. Shares of Common Stock registered hereby
include (i) 20,101 shares of Common Stock issuable upon the
conversion of Series A Preferred Stock, (ii) 20,101 shares of
Common Stock issuable upon the exercise of Series A Warrants and
(iii) an estimated 24,205 shares of Common Stock that may be
issuable in respect of accrued but unpaid dividends on shares of
Series A Preferred Stock. Mr. Busch is a partner at K&amp;L Gates
LLP, our outside counsel. See &#x201C;Legal
Matters.&#x201D;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(114)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(115)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 73,725 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 73,725 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 88,779 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(116)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(117)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 50,252 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 50,252 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 60,513 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(118)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(119)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 48,599 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 48,599 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 58,523 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(120)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(121)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(122)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">24</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(123)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(124)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(125)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 97,198 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 97,198 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 117,045 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(126)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 122,323 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 122,323 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 147,301 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(127)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(128)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 251,257 shares of Common Stock issued
in the First Private Placement and (ii) 251,257 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(129)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 25,126 shares of Common Stock issued
in the First Private Placement and (ii) 25,126 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(130)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 150,754 shares of Common Stock issued
in the First Private Placement and (ii) 150,754 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(131)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issued in the First Private Placement and issuable
upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 251,257 shares of Common Stock issued
in the First Private Placement and (ii) 251,257 shares of Common
Stock issuable upon the exercise of Series A Warrants.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(132)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 50,252 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 50,252 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 60,513 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(133)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">25</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(134)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 25,126 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 25,126 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 30,257 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(135)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 72,072 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 72,072 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 86,789 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(136)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 38,549 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 38,549 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 46,420 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(137)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 15,076 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 15,076 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 18,154 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(138)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 43,574 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 43,574 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 52,472 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(139)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(140)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock issuable upon the conversion of Series A Preferred
Stock and issuable upon exercise of Series A Warrants. Shares of
Common Stock registered hereby include (i) 23,474 shares of Common
Stock issuable upon the conversion of Series A Preferred Stock,
(ii) 23,474 shares of Common Stock issuable upon the exercise of
Series A Warrants and (iii) an estimated 28,267 shares of Common
Stock that may be issuable in respect of accrued but unpaid
dividends on shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(141)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 10,051 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
10,051 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 12,103 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock. Mr. Wells has served as our
Chief Financial Officer since 2014.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(142)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 20,101 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
20,101 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 24,205 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(143)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 25,126 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
25,126 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 30,257 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">26</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(144)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 15,076 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
15,076 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 18,154 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(145)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 50,252 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
50,252 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 60,513 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(146)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 20,101 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
20,101 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 24,205 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(147)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 48,599 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
48,599 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 58,523 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(148)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 25,126 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
25,126 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 30,257 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 0px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">(149)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Common Stock
beneficially owned prior to the offering consists of shares of
Common Stock owned prior to the First Private Placement, shares
issuable upon exercise of stock options and restricted warrants and
shares issuable upon the conversion of Series A Preferred Stock and
issuable upon exercise of Series A Warrants. Shares of Common Stock
registered hereby include (i) 48,599 shares of Common Stock
issuable upon the conversion of Series A Preferred Stock, (ii)
48,599 shares of Common Stock issuable upon the exercise of Series
A Warrants and (iii) an estimated 58,523 shares of Common Stock
that may be issuable in respect of accrued but unpaid dividends on
shares of Series A Preferred Stock.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">27</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
PLAN OF DISTRIBUTION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders, which as used herein includes donees,
pledgees, transferees or other successors-in-interest selling
shares of Common Stock or interests in shares of Common Stock
received after the date of this prospectus from a Selling
Stockholder as a gift, pledge, partnership distribution or other
transfer, may, from time to time, sell, transfer or otherwise
dispose of any or all of their shares of Common Stock or interests
in shares of Common Stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions.
These dispositions may be at fixed prices, at prevailing market
prices at the time of sale, at prices related to the prevailing
market price, at varying prices determined at the time of sale, or
at negotiated prices.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders may use any one or more of the following
methods when disposing of shares or interests therein:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">ordinary brokerage
transactions and transactions in which the broker-dealer solicits
purchasers;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">block trades in
which the broker-dealer will attempt to sell the shares as agent,
but may position and resell a portion of the block as principal to
facilitate the transaction;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">purchases by a
broker-dealer as principal and resale by the broker-dealer for its
account;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">an exchange
distribution in accordance with the rules of the applicable
exchange;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">privately
negotiated transactions;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">short sales
effected after the date the registration statement of which this
prospectus is a part is declared effective by the SEC;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">through the writing
or settlement of options or other hedging transactions, whether
through an options exchange or otherwise;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">broker-dealers may
agree with the Selling Stockholders to sell a specified number of
such shares at a stipulated price per share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">a combination of
any such methods of sale; and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">any other method
permitted by applicable law.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders may, from time to time, pledge or grant a
security interest in some or all of the shares of Common Stock
owned by them and, if they default in the performance of their
secured obligations, the pledgees or secured parties may offer and
sell the shares of Common Stock, from time to time, under this
prospectus, or under an amendment to this prospectus under Rule
424(b)(3) or other applicable provision of the Securities Act
amending the list of Selling Stockholders to include the pledgee,
transferee or other successors in interest as Selling Stockholders
under this prospectus. The Selling Stockholders also may transfer
the shares of Common Stock in other circumstances, in which case
the transferees, pledgees or other successors in interest will be
the selling beneficial owners for purposes of this
prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
connection with the sale of the Securities or interests therein,
the Selling Stockholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn
engage in short sales of the Securities in the course of hedging
the positions they assume. The Selling Stockholders may also sell
shares of our Common Stock short and deliver the Securities to
close out their short positions, or loan or pledge the Securities
to broker-dealers that in turn may sell the Securities. The Selling
Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or the creation of
one or more derivative securities which require the delivery to
such broker-dealer or other financial institution of shares offered
by this prospectus, which shares such broker-dealer or other
financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction).</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
aggregate proceeds to the Selling Stockholders from the sale of the
Securities offered by them will be the purchase price of the
Securities less discounts or commissions, if any. Each of the
Selling Stockholders reserves the right to accept and, together
with their agents from time to time, to reject, in whole or in
part, any proposed purchase of Securities to be made directly or
through agents. We will not receive any of the proceeds from this
offering, although we will receive the exercise price of any
exercised Series A Warrants or Series B Warrants paid to us by the
Selling Stockholders or their transferees, which will be used for
working capital and general corporate purposes.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders also may resell all or a portion of the
Securities in open market transactions in reliance upon Rule 144
under the Securities Act, provided that they meet the criteria and
conform to the requirements of that rule.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">28</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Selling Stockholders and any underwriters, broker-dealers or agents
that participate in the sale of the Securities or interests therein
may be &#x201C;underwriters&#x201D; within the meaning of Section
2(11) of the Securities Act. Any discounts, commissions,
concessions or profit they earn on any resale of the Securities may
be underwriting discounts and commissions under the Securities Act.
Selling Stockholders who are &#x201C;underwriters&#x201D; within the
meaning of Section 2(11) of the Securities Act will be subject to
the prospectus delivery requirements of the Securities
Act.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">To the
extent required, the shares of our Common Stock to be sold, the
names of the Selling Stockholders, the respective purchase prices
and public offering prices, the names of any agents, dealer or
underwriter, any applicable commissions or discounts with respect
to a particular offer will be set forth in an accompanying
prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement that includes this
prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
order to comply with the securities laws of some states, if
applicable, the Securities may be sold in these jurisdictions only
through registered or licensed brokers or dealers. In addition, in
some states the Securities may not be sold unless they been
registered or qualified for sale or an exemption from registration
or qualification requirements is available and is complied
with.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
advised the Selling Stockholders that the anti-manipulation rules
of Regulation M under the Exchange Act may apply to sales of
Securities in the market and to the activities of the Selling
Stockholders and their affiliates. In addition, to the extent
applicable, we will make copies of this prospectus (as it may be
supplemented or amended from time to time) available to the Selling
Stockholders for the purpose of satisfying the prospectus delivery
requirements of the Securities Act. The Selling Stockholders may
indemnify any broker-dealer that participates in transactions
involving the sale of the Securities against certain liabilities,
including liabilities arising under the Securities
Act.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
agreed to indemnify the Selling Stockholders against liabilities,
including liabilities under the Securities Act and state securities
laws, relating to the registration of the Securities offered by
this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
agreed with the Selling Stockholders to use commercially reasonable
efforts to keep the registration statement of which this prospectus
is a part effective until the earlier of (1) such time as all of
the Securities covered by this prospectus have been sold or (2) the
date on which all of the Securities may be sold without restriction
pursuant to Rule 144 of the Securities Act.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">29</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
DESCRIPTION OF CAPITAL STOCK</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following is a brief description of our capital stock. This summary
does not purport to be complete in all respects. This description
is subject to and qualified entirely by the terms of our Fourth
Amended and Restated Certificate of Incorporation (the
&#x201C;Certificate of Incorporation&#x201D;), the Series A
Certificate of Designations, the Series B Certificate of
Designations and our amended and restated bylaws, copies of which
have been filed with the SEC and are also available upon request
from us.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Authorized Capitalization</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
60,000,000 shares of capital stock authorized under our Certificate
of Incorporation, consisting of 50,000,000 shares of common stock
with a par value of $0.0001 per share (&#x201C;Common Stock&#x201D;)
and 10,000,000 shares of preferred stock with a par value of
$0.0001 per share (&#x201C;Preferred Stock&#x201D;), of which 10,000
shares have been designated Series A Convertible Preferred Stock
and 1,000 shares have been designated Series B Convertible
Preferred Stock. As of December 31, 2019, we had 8,420,401 shares
of Common Stock issued and outstanding held of record by 41
stockholders, 6,338.490 shares of Series A Preferred Stock issued
and outstanding held of record by 144 stockholders and 351.712
shares of Series B Preferred Stock issued and outstanding held of
record by seven stockholders. Our authorized but unissued shares of
Common Stock and Preferred Stock are available for issuance without
further action by our stockholders, unless such action is required
by applicable law or the rules of any stock exchange or automated
quotation system on which our securities may be listed or
traded.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Common Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
holders of outstanding shares of Common Stock are entitled to such
dividends as may be declared by our board of directors out of funds
legally available for such purpose. The shares of Common Stock are
neither redeemable nor convertible. Holders of Common Stock have no
preemptive or subscription rights to purchase any of our
securities.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Each
holder of our Common Stock is entitled to one vote for each such
share outstanding in the holder&#x2019;s name. No holder of Common
Stock is entitled to cumulate votes in voting for
directors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In the
event of our liquidation, dissolution or winding up, the holders of
our Common Stock are entitled to receive pro rata our assets, which
are legally available for distribution, after payments of all debts
and other liabilities. All of the outstanding shares of our Common
Stock are fully paid and non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
shares of Common Stock are listed on the Nasdaq Capital Market
under the symbol &#x201C;NDRA.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Preferred Stock</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
board of directors has the authority, without further action by the
stockholders, to issue up to 10,000,000 shares of Preferred Stock
in one or more series and to fix the designations, powers, rights,
preferences, qualifications, limitations and restrictions thereof.
These designations, powers, rights and preferences could include
voting rights, dividend rights, dissolution rights, conversion
rights, exchange rights, redemption rights, liquidation
preferences, and the number of shares constituting any series or
the designation of such series, any or all of which may be greater
than the rights of Common Stock. The issuance of Preferred Stock
could adversely affect the voting power of holders of Common Stock
and the likelihood that such holders will receive dividend payments
and payments upon liquidation. In addition, the issuance of
Preferred Stock could have the effect of delaying, deferring or
preventing change in our control or other corporate
action.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Series A Convertible Preferred Stock.</font> <font style="color: #000000">Each share of Series A Preferred Stock has a
Series A Issue Price of $1,000. Dividends accrue on the Series A
Issue Price at a rate of 6.0% per annum and are payable to holders
of Series A Preferred Stock as, when and if declared by our Board
of Directors.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Shares of Series A Preferred Stock, including accrued but unpaid
dividends, are convertible into Common Stock at a conversion price
of $0.87 per share of Common Stock. The conversion price is subject
to proportional adjustment for certain transactions relating to our
capital stock, including stock splits, stock dividends and similar
transactions. Holders may convert their shares of Series A
Preferred Stock into Common Stock at any time and we have the right
to cause each holder to convert their shares of Series A Preferred
Stock in the event that (i) the average of the daily
volume-weighted average price of Common Stock over any 10
consecutive trading days is greater than $1.74 (as adjusted for
stock splits, stock dividends and similar transactions) and (ii)
there is then an effective registration statement registering under
the Securities Act the resale of the shares of Common Stock
issuable upon such conversion of Series A Preferred
Stock.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Holders of Series A Preferred Stock are entitled to a liquidation
preference in the event of any liquidation, dissolution or winding
up of the Company based on their shares&#x2019; aggregate Series A
Issue Price and accrued and unpaid dividends.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">30</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Holders of shares of Series A Preferred Stock vote with the holders
of Common Stock and are entitled to a number of votes equal to the
number of shares of Common Stock into which such holder&#x2019;s
shares of Series A Preferred Stock are then
convertible.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic; color: #000000">
Series B Convertible Preferred Stock.</font> <font style="color: #000000">Each share of Series B Preferred Stock has a
Series B Issue Price of $1,000. Dividends accrue on the Series B
Issue Price at a rate of 6.0% per annum and are payable to holders
of Series B Preferred Stock as, when and if declared by our Board
of Directors.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Shares of Series B Preferred Stock, including accrued but unpaid
dividends, are convertible into Common Stock at a conversion price
of $0.99 per share of Common Stock. The conversion price is subject
to proportional adjustment for certain transactions relating to our
capital stock, including stock splits, stock dividends and similar
transactions. Holders may convert their shares of Series B
Preferred Stock into Common Stock at any time and we have the right
to cause each holder to convert their shares of Series B Preferred
Stock in the event that (i) the average of the daily
volume-weighted average price of Common Stock over any 10
consecutive trading days is greater than $1.98 (as adjusted for
stock splits, stock dividends and similar transactions) and (ii)
there is then an effective registration statement registering under
the Securities Act the resale of the shares of Common Stock
issuable upon such conversion of Series B Preferred
Stock.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">
Holders of Series B Preferred Stock are entitled to a liquidation
preference in the event of any liquidation, dissolution or winding
up of the Company based on their shares&#x2019; aggregate Series B
Issue Price and accrued and unpaid dividends. &#xA0;Such
liquidation preference of Series B Preferred Stock holders is on
a</font> <font style="font-style: italic; color: #000000">pari
passu</font> <font style="color: #000000">basis with holders of
Series A Preferred Stock.</font></font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Holders of shares of Series B Preferred Stock vote with the holders
of Common Stock, and with any other shares of preferred stock that
vote with the Common Stock, and are entitled to a number of votes
equal to the number of shares of Common Stock into which such
holder&#x2019;s shares of Series B Preferred Stock are then
convertible.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Stock Options and Warrants</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As of
December 31, 2019, we had reserved the following shares of Common
Stock for issuance pursuant to stock options, warrants and equity
plans:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">1,932,000 shares of
Common Stock issuable upon the exercise of outstanding warrants
issued in our initial public offering listed on the Nasdaq Capital
Market under the symbol &#x201C;NDRAW,&#x201D; at an exercise price
of $6.25 per share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">2,606,566 shares of
Common Stock issuable upon the exercise of outstanding unregistered
warrants, at a weighted average exercise price of $2.83 per
share;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">3,413,728 shares of
our Common Stock issuable upon the exercise of outstanding stock
options issued pursuant to our Incentive Plan at a weighted average
exercise price of $1.80 per share; and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">1,109,532 shares of
our Common Stock reserved for future issuance under our Incentive
Plan.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Other Convertible Securities</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">On July
26, 2019, we issued $2.59 million aggregate principal amount of
10.0% Senior Secured Convertible Notes due 2020 (the
&#x201C;Notes&#x201D;) sold in a private placement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Each Note bears interest at a rate of 10% per annum until maturity
on April 26, 2020 (the &#x201C;Maturity Date&#x201D;). Interest will
be paid in arrears on the outstanding principal amount on the three
month anniversary of the issuance of the Notes and each three month
period thereafter and on the Maturity Date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
Holders of Notes (&#x201C;Noteholders&#x201D;) are entitled to
convert principal and accrued, unpaid interest on the Notes into
shares of Common Stock. As of December 31, 2019, the Notes were
convertible into 371,517 shares of Common Stock at a conversion
price per share equal to $1.49 and we had additionally reserved an
estimated 6,426 shares that may be issued in respect of accrued and
unpaid interest upon conversion of such Notes.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
The Notes provide for customary events of default. In the case of
an event of default with respect to the Notes, each Noteholder may
declare its Note to be due and payable immediately without further
action or notice. If an event of default occurs and is continuing,
interest on the Notes will automatically be increased to 18% until
the default is cured.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">31</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
GE Healthcare Right</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
April 2016, we entered into a Collaborative Research Agreement with
General Electric Company, acting through its GE Healthcare business
unit and the GE Global Research Center, or GE Healthcare. The
agreement provides that prior to selling any equity interests in
our company to a healthcare device manufacturer, we will first
offer to negotiate in good faith to sell such equity interests to
GE Healthcare.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Transfer Agent</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
transfer agent of our Common Stock offered hereby is Corporate
Stock Transfer, Inc., 3200 Cherry Creek Dr. South, Suite 430,
Denver, CO 80209. Its telephone number is (303)
282-4800.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Anti-Takeover Effects of Certain Provisions of Delaware Law and Our
Charter Documents</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following is a summary of certain provisions of Delaware law, our
Certificate of Incorporation and our bylaws. This summary does not
purport to be complete and is qualified in its entirety by
reference to the corporate law of Delaware and our Certificate of
Incorporation and bylaws.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Effect of Delaware Anti-Takeover Statute</font>. We are subject to
Section 203 of the Delaware General Corporation Law, an
anti-takeover law. In general, Section 203 prohibits a Delaware
corporation from engaging in any business combination (as defined
below) with any interested stockholder (as defined below) for a
period of three years following the date that the stockholder
became an interested stockholder, unless:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">prior to that date,
the board of directors of the corporation approved either the
business combination or the transaction that resulted in the
stockholder becoming an interested stockholder;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">upon consummation
of the transaction that resulted in the stockholder becoming an
interested stockholder, the interested stockholder owned at least
85% of the voting stock of the corporation outstanding at the time
the transaction commenced, excluding for purposes of determining
the number of shares of voting stock outstanding (but not the
voting stock owned by the interested stockholder) those shares
owned by persons who are directors and officers and by excluding
employee stock plans in which employee participants do not have the
right to determine whether shares held subject to the plan will be
tendered in a tender or exchange offer; or</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">on or subsequent to
that date, the business combination is approved by the board of
directors of the corporation and authorized at an annual or special
meeting of stockholders, and not by written consent, by the
affirmative vote of at least 66 2/3% of the outstanding voting
stock that is not owned by the interested stockholder.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Section
203 defines &#x201C;business combination&#x201D; to include the
following:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">any merger or
consolidation involving the corporation and the interested
stockholder;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">any sale, transfer,
pledge or other disposition of 10% or more of the assets of the
corporation involving the interested stockholder;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">subject to certain
exceptions, any transaction that results in the issuance or
transfer by the corporation of any stock of the corporation to the
interested stockholder;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">subject to limited
exceptions, any transaction involving the corporation that has the
effect of increasing the proportionate share of the stock of any
class or series of the corporation beneficially owned by the
interested stockholder; or</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">the receipt by the
interested stockholder of the benefit of any loans, advances,
guarantees, pledges or other financial benefits provided by or
through the corporation.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In
general, Section 203 defines an interested stockholder as any
entity or person beneficially owning 15% or more of the outstanding
voting stock of the corporation, or who beneficially owns 15% or
more of the outstanding voting stock of the corporation at any time
within a three-year period immediately prior to the date of
determining whether such person is an interested stockholder, and
any entity or person affiliated with or controlling or controlled
by any of these entities or persons.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Our Charter Documents</font>. Our charter documents include
provisions that may have the effect of discouraging, delaying or
preventing a change in control or an unsolicited acquisition
proposal that a stockholder might consider favorable, including a
proposal that might result in the payment of a premium over the
market price for the shares held by our stockholders. Certain of
these provisions are summarized in the following
paragraphs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">32</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Effects of authorized but unissued common stock</font>. One of the
effects of the existence of authorized but unissued common stock
may be to enable our board of directors to make more difficult or
to discourage an attempt to obtain control of our Company by means
of a merger, tender offer, proxy contest or otherwise, and thereby
to protect the continuity of management. If, in the due exercise of
its fiduciary obligations, the board of directors were to determine
that a takeover proposal was not in our best interest, such shares
could be issued by the board of directors without stockholder
approval in one or more transactions that might prevent or render
more difficult or costly the completion of the takeover transaction
by diluting the voting or other rights of the proposed acquirer or
insurgent stockholder group, by putting a substantial voting block
in institutional or other hands that might undertake to support the
position of the incumbent board of directors, by effecting an
acquisition that might complicate or preclude the takeover, or
otherwise.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Cumulative Voting</font>. Our Certificate of Incorporation does not
provide for cumulative voting in the election of directors, which
would allow holders of less than a majority of the stock to elect
some directors.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Vacancies</font>. Our Certificate of Incorporation provides that
all vacancies may be filled by the affirmative vote of a majority
of directors then in office, even if less than a
quorum.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-style: italic">
Special Meeting of Stockholders</font>. A special meeting of
stockholders may only be called by the Chairman of the board of
directors, the President, the Chief Executive Officer, or the board
of directors at any time and for any purpose or purposes as shall
be stated in the notice of the meeting, or by request of the
holders of record of at least 20% of the outstanding shares of
common stock. This provision could prevent stockholders from
calling a special meeting because, unless certain significant
stockholders were to join with them, they might not obtain the
percentage necessary to request the meeting. Therefore,
stockholders holding less than 20% of the issued and outstanding
common stock, without the assistance of management, may be unable
to propose a vote on any transaction that would delay, defer or
prevent a change of control, even if the transaction were in the
best interests of our stockholders.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
LEGAL MATTERS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
validity of the Securities offered hereby has been passed upon for
us by K&amp;L Gates LLP, Charlotte, North Carolina. As described
under &#x201C;Selling Stockholders,&#x201D; Mark R. Busch, a partner
at K&amp;L Gates LLP, beneficially owns certain of our securities
and is participating as a selling stockholder in this
offering.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
EXPERTS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
financial statements of ENDRA Life Sciences Inc. as of December 31,
2018 and December 31, 2017 included in the Annual Report on Form
10-K for the year ended December 31, 2018 have been audited by RBSM
LLP, independent registered public accounting firm, as stated in
their report, which is incorporated herein by reference. We have
incorporated these financial statements by reference in reliance
upon the report of RBSM LLP, given upon their authority as experts
in accounting and auditing.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">33</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
WHERE YOU CAN FIND MORE INFORMATION</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We have
filed with the SEC a Registration Statement on Form S-3 under the
Securities Act to register the Securities offered by this
prospectus. The term &#x201C;registration statement&#x201D; means the
original registration statement and any and all amendments thereto,
including the schedules and exhibits to the original registration
statement or any amendment. This prospectus is part of that
registration statement. This prospectus does not contain all of the
information set forth in the registration statement or the exhibits
to the registration statement. For further information with respect
to us and the Securities being offered pursuant to this prospectus,
you should refer to the registration statement and its exhibits.
Statements contained in this prospectus as to the contents of any
contract, agreement or other document referred to are not
necessarily complete, and you should refer to the copy of that
contract or other documents filed as an exhibit to the registration
statement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We file
annual reports, quarterly reports, current reports, proxy
statements and other information with the SEC under the Exchange
Act. You can read our SEC filings, including the registration
statement, at the SEC&#x2019;s website at <font style="text-decoration: underline;">www.sec.gov</font>, which contains
reports, proxy and information statements and other information
regarding issuers that file electronically with the
SEC.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Our
website can be accessed at www.endrainc.com. The information
contained on, or that may be obtained from, our website is not, and
shall not be deemed to be, a part of this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
representations, warranties and covenants made by us in any
agreement that is filed as an exhibit to the registration statement
of which this prospectus is a part were made solely for the benefit
of the parties to such agreement, including, in some cases, for the
purpose of allocating risk among the parties to such agreements,
and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or
covenants were made as of an earlier date. Accordingly, such
representations, warranties and covenants should not be relied on
as accurately representing the current state of our
affairs.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
prospectus includes statistical and other industry and market data
that we obtained from industry publications and research, surveys
and studies conducted by third parties. Industry publications and
third-party research, surveys and studies generally indicate that
they have gathered their information from sources they believe to
be reliable, although they do not guarantee the accuracy or
completeness of such information. While we believe that these
industry publications and third-party research, surveys and studies
are reliable, we have not independently verified such
data.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">34</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The SEC
allows us to &#x201C;incorporate by reference&#x201D; information
from other documents that we file with it, which means that we can
disclose important information to you by referring you to those
documents. The information incorporated by reference is considered
to be part of this prospectus. Information in this prospectus
supersedes information incorporated by reference that we filed with
the SEC prior to the date of this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We
incorporate by reference into this prospectus and the registration
statement of which this prospectus is a part the information or
documents listed below that we have filed with the
SEC:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our annual report
on Form 10-K for the fiscal year ended December 31, 2018 filed with
the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419002560/ndra_10k.htm">
<font style="text-decoration: underline;">March 11,
2019</font></a>;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our quarterly
reports on Form 10-Q for the fiscal quarter ended March 31, 2019
filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419005939/ndra_10q.htm">
<font style="text-decoration: underline;">May 14, 2019</font></a>,
for the fiscal quarter ended June 30, 2019 filed with the SEC on
<a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419009079/ndra_10q.htm">
<font style="text-decoration: underline;">August 8, 2019</font></a>
and for the fiscal quarter ended September 30, 2019 filed with the
SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419012855/ndra_10q.htm">
<font style="text-decoration: underline;">November 13,
2019</font></a>;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our Current Reports
on Form 8-K filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419006338/ndra_8k.htm">
<font style="text-decoration: underline;">May 20, 2019</font></a>,
<a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419008564/ndra_8k.htm">
<font style="text-decoration: underline;">July 29, 2019</font></a>,
<a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419009726/endra_8k.htm">
<font style="text-decoration: underline;">August 16,
2019</font></a>, <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013822/ndra_8k.htm">
<font style="text-decoration: underline;">December 11,
2019</font></a>, as amended on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013920/ndra_8ka.htm">
<font style="text-decoration: underline;">December 13,
2019</font></a>, <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419014235/ndra_8k.htm">
<font style="text-decoration: underline;">December 26,
2019</font></a>, and <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419014269/ndra_8k.htm">
<font style="text-decoration: underline;">December 27,
2019</font></a>;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">our Definitive
Proxy Statement on Schedule 14A related to our 2019 Annual Meeting
of Stockholders, filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000121390019006402/def14a0419_endralife.htm">
<font style="text-decoration: underline;">April 15,
2019</font></a>; and</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">the description of
our Common Stock contained in our Registration Statement on Form
8-A (File No. 001-37969) filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495416004941/end_8a12b.htm">
<font style="text-decoration: underline;">December 16,
2016</font></a>, including any amendment or reports filed for the
purpose of updating such description.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We also
incorporate by reference any future filings (other than current
reports furnished under Item 2.02 or Item 7.01 of Form 8-K and
exhibits filed on such form that are related to such items unless
such Form 8-K expressly provides to the contrary) made with the SEC
pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act,
including those made on or after the date of the initial filing of
the registration statement of which this prospectus is a part and
prior to effectiveness of such registration statement, until we
file a post-effective amendment that indicates the termination of
the offering of the Securities made by this prospectus and will
become a part of this prospectus from the date that such documents
are filed with the SEC. Information in such future filings updates
and supplements the information provided in this prospectus. Any
statements in any such future filings will automatically be deemed
to modify and supersede any information in any document we
previously filed with the SEC that is incorporated or deemed to be
incorporated herein by reference to the extent that statements in
the later filed document modify or replace such earlier
statements.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We will
furnish without charge to you, on written or oral request, a copy
of any or all of the documents incorporated by reference, including
exhibits to these documents. You should direct any requests for
documents to ENDRA Life Sciences Inc., 3600 Green Court, Suite 350,
Ann Arbor, Michigan 48105; Telephone: (734) 335-0468. Copies of the
above reports may also be accessed from our website at
www.endrainc.com. We have authorized no one to provide you with any
information that differs from that contained in this prospectus.
Accordingly, you should not rely on any information that is not
contained in this prospectus. You should not assume that the
information in this prospectus is accurate as of any date other
than the date on the front cover of this prospectus.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Any
statement contained in a document incorporated or deemed to be
incorporated by reference in this prospectus will be deemed
modified, superseded or replaced for purposes of this prospectus to
the extent that a statement contained in this prospectus modifies,
supersedes or replaces such statement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">35</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div><font>&#xA0;</font></div>
<img src="ndra_s3003.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
ENDRA Life Sciences Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
25,644,002 Shares of Common Stock for sale by the Selling
Stockholders</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
PROSPECTUS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
January , 2020</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
PART II</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
INFORMATION NOT REQUIRED IN PROSPECTUS</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 14. Other Expenses of Issuance and Distribution.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Set
forth below is an estimate (except for registration fees, which are
actual) of the approximate amount of the fees and expenses payable
by us in connection with the issuance and distribution of the
Securities. The Selling Stockholders will not be responsible for
any of the expenses of this offering.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr style="background-color:#cceeff;">
<td rowspan="1" style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">SEC registration
fee</font></div>
</td>
<td rowspan="1" style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">6,141</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Accounting fees and
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">15,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Legal fees and
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">50,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Miscellaneous</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">3,859</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:88%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">Total</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">$</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">75,000</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 15. Indemnification of Directors and Officers.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
following summary is qualified in its entirety by reference to the
complete text of any statutes referred to below and the Fourth
Amended and Restated Certificate of Incorporation of ENDRA Life
Sciences Inc., a Delaware corporation.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Section
145 of the General Corporation Law of the State of Delaware (the
&#x201C;DGCL&#x201D;) permits a Delaware corporation to indemnify any
person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other
than an action by or in the right of the corporation) by reason of
the fact that the person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other
enterprise, against expenses (including attorneys&#x2019; fees),
judgments, fines and amounts paid in settlement actually and
reasonably incurred by the person in connection with such action,
suit or proceeding if the person acted in good faith and in a
manner the person reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any
criminal action or proceeding, had no reasonable cause to believe
the person&#x2019;s conduct was unlawful.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">In the
case of an action by or in the right of the corporation, Section
145 of the DGCL permits a Delaware corporation to indemnify any
person who was or is a party or is threatened to be made a party to
any threatened, pending or completed action or suit by reason of
the fact that the person is or was a director, officer, employee or
agent of the corporation, or is or was serving at the request of
the corporation as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other
enterprise, against expenses (including attorneys&#x2019; fees)
actually and reasonably incurred by the person in connection with
such action, suit or proceeding if the person acted in good faith
and in a manner the person reasonably believed to be in or not
opposed to the best interests of the corporation and except that no
indemnification shall be made in respect of any claim, issue or
matter as to which such person shall have been adjudged to be
liable to the corporation unless and only to the extent that the
Court of Chancery or the court in which such action or suit was
brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of
the case, such person is fairly and reasonably entitled to
indemnity for such expenses that the Court of Chancery or such
other court shall deem proper.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Section
145 of the DGCL also permits a Delaware corporation to purchase and
maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation, or is or
was serving at the request of the corporation as a director,
officer, employee or agent of another corporation, partnership,
joint venture, trust or other enterprise against any liability
asserted against such person and incurred by such person in any
such capacity, or arising out of such person&#x2019;s status as
such, whether or not the corporation would have the power to
indemnify such person against such liability under Section 145 of
the DGCL.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Article
NINTH of our Fourth Amended and Restated Certificate of
Incorporation states that our directors shall not be personally
liable to us or to our stockholders for monetary damages for any
breach of fiduciary duty as a director, notwithstanding any
provision of law imposing such liability. Under Section 102(b)(7)
of the DGCL, the personal liability of a director to the
corporation or its stockholders for monetary damages for breach of
fiduciary duty can be limited or eliminated except (i) for any
breach of the director&#x2019;s duty of loyalty to the corporation
or its stockholders; (ii) for acts or omissions not in good faith
or which involve intentional misconduct or a knowing violation of
law; (iii) under Section 174 of the DGCL (relating to unlawful
payment of dividend or unlawful stock purchase or redemption); or
(iv) for any transaction from which the director derived an
improper personal benefit.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Article
EIGHTH of our Fourth Amended and Restated Certificate of
Incorporation provides that we shall indemnify (and advance
expenses to) our officers and directors to the full extent
permitted by the DGCL.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">All of
the Company&#x2019;s directors and officers are covered by insurance
policies maintained by the Company against specified liabilities
for actions taken in their capacities as such, including
liabilities under the Securities Act. Such insurance also insures
us against losses which we may incur in indemnifying our officers
and directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">II-1</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">As
permitted by the DGCL, we have entered into indemnification
agreements with each of our directors and executive officers that
require us to indemnify them against various actions including, but
not limited to, third-party actions where such director or
executive officer, by reason of his or her corporate status, is a
party or is threatened to be made a party to an action, or by
reason of anything done or not done by such director in any such
capacity. We indemnify directors and executive officers against all
costs, judgments, penalties, fines, liabilities, amounts paid in
settlement by or on behalf of such directors or executive officers
and for any expenses actually and reasonably incurred by such
directors or executive officers in connection with such action, if
such directors or executive officers acted in good faith and in a
manner they reasonably believed to be in or not opposed to our best
interests, and with respect to any criminal proceeding, had no
reasonable cause to believe their conduct was unlawful. We also
intend to advance to our directors and executive officers expenses
(including attorney&#x2019;s fees) incurred by or on behalf of such
directors and executive officers in advance of the final
disposition of any action after our receipt of a statement or
statements from directors or executive officers requesting such
payment or payments from time to time, provided that such statement
or statements are preceded or accompanied by a written undertaking,
by or on behalf of such directors or executive officers, to repay
such amount if it shall ultimately be determined that they are not
entitled to be indemnified against such expenses by
us.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
indemnification agreements also set forth certain procedures that
will apply in the event of a claim for indemnification or
advancement of expenses, including, among others, provisions about
submitting a written request to us that includes such documentation
and information as is reasonably available to the director or
executive officer and is reasonably necessary to determine
entitlement to indemnification and provisions.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 16. Exhibits and Financial Statement Schedules.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td colspan="2" style="vertical-align: top; width: 46%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="6" style="vertical-align: top; width: 54%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Incorporated by Reference</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 12%; border-bottom: 2px solid #000000">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit Number</font></div>
</td>
<td style="vertical-align: bottom; width: 33%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit Description</font></div>
</td>
<td style="vertical-align: bottom; width: 12%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Filed Herewith</font></div>
</td>
<td style="vertical-align: bottom; width: 7%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Form</font></div>
</td>
<td style="vertical-align: bottom; width: 9%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit</font></div>
</td>
<td style="vertical-align: bottom; width: 10%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Filing Date</font></div>
</td>
<td style="vertical-align: bottom; width: 16%; border-bottom: 2px solid #000000">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Registration/File No.</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495416004197/end_ex41.htm">
<font style="font-size: 13px; font-family: Times New Roman;">4.1</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Specimen
Certificate representing shares of common stock of the
Registrant</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">S-1</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.1</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">11/21/16</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">333-214724</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013822/ndra_ex41.htm">
<font style="font-size: 13px; font-family: Times New Roman;">4.2</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certificate
of Designations of Series A Convertible Preferred
Stock</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.1</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/11/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419014235/ndra_ex41.htm">
<font style="font-family: Times New Roman; font-size: 13px;">4.3</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Certificate
of Designations of Series B Convertible Preferred
Stock</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.1</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/26/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013822/ndra_ex42.htm">
<font style="font-family: Times New Roman; font-size: 13px;">4.4</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Series A Warrant</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.2</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/11/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419014235/ndra_ex42.htm">
<font style="font-size: 13px; font-family: Times New Roman;">4.5</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Series B Warrant</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">4.2</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/26/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013822/ndra_ex101.htm">
<font style="font-size: 13px; font-family: Times New Roman;">4.6</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Securities Purchase Agreement dated December 5, 2019</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10.1</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/11/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419014235/ndra_ex101.htm">
<font style="font-family: Times New Roman; font-size: 13px;">4.7</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Securities Purchase Agreement dated December 19, 2019</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10.1</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/26/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="http://www.sec.gov/Archives/edgar/data/1681682/000165495419013822/ndra_ex102.htm">
<font style="font-size: 13px; font-family: Times New Roman;">4.8</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Form of
Registration Rights Agreement</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 7%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">8-K</font></div>
</td>
<td style="vertical-align: top; width: 9%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">10.2</font></div>
</td>
<td style="vertical-align: top; width: 10%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">12/11/19</font></div>
</td>
<td style="vertical-align: top; width: 16%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">001-37969</font></div>
</td>
<td style="vertical-align: top; width: 0%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="ndra_ex51.htm"><font style="font-family: Times New Roman; font-size: 13px">5.1</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Opinion
of K&amp;L Gates LLP</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">X</font></div>
</td>
<td colspan="5" style="vertical-align: top; width: 42%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><a href="ndra_ex231.htm"><font style="font-family: Times New Roman; font-size: 13px">23.1</font></a></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consent
of RBSM LLP, Independent Registered Public Accounting
Firm</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">X</font></div>
</td>
<td colspan="5" style="vertical-align: top; width: 42%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">23.2</font></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Consent
of K&amp;L Gates LLP (contained in Exhibit 5.1)</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">X</font></div>
</td>
<td colspan="5" style="vertical-align: top; width: 42%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 12%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-size: 13px; font-family: Times New Roman;">24.1</font></div>
</td>
<td style="vertical-align: top; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Power
of Attorney (included on signature page)</font></div>
</td>
<td style="vertical-align: top; width: 12%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">X</font></div>
</td>
<td colspan="5" style="vertical-align: top; width: 42%">
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Item 17. Undertakings.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Insofar
as indemnification for liabilities arising under the Securities Act
of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the provisions described
under Item 15 or otherwise, the registrant has been advised that in
the opinion of the Commission such indemnification by it is against
public policy as expressed in the Securities Act of 1933 and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities, other than the payment by
the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense
of any action, suit or proceeding, is asserted by such director,
officer or controlling person in connection with the securities
being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in
the Securities Act of 1933 and will be governed by the final
adjudication of such issue.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">(a)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">The undersigned
registrant hereby undertakes:</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">1.&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">To file, during any
period in which offers or sales are being made, a post-effective
amendment to this registration statement:</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px">i.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">II-2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div>&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px">ii.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form
of a prospectus filed with the SEC pursuant to Rule 424(b) under
the Securities Act if, in the aggregate, the changes in volume and
price represent no more than 20% change in the maximum aggregate
offering price set forth in the &#x201C;Calculation of Registration
Fee&#x201D; table in the effective registration statement;
and</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px">
<font style="font-family: Times New Roman; font-size: 13px">iii.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;To
include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 48px; margin-right: 0px; text-indent: -48px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="text-decoration: underline">provided</font>, <font style="text-decoration: underline">however</font>, that paragraphs
(a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply
if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or
furnished to the SEC by the registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934 (the
&#x201C;Exchange Act&#x201D;) that are incorporated by reference in
the registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the registration
statement.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">2.&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">That, for the
purpose of determining any liability under the Securities Act of
1933, each such post-effective amendment shall be deemed to be a
new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 48px">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">3.&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">To remove from
registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination
of the offering.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">(b)&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">The undersigned
registrant hereby undertakes that, for the purpose of determining
liability under the Securities Act of 1933 to any purchaser, each
prospectus filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration
statements relying on Rule 430B or other than prospectuses filed in
reliance on Rule 430A, shall be deemed to be part of and included
in the registration statement as of the date it is first used after
effectiveness; provided, however, that no statement made in a
registration statement or prospectus that is part of the
registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or
prospectus that is part of the registration statement will, as to a
purchaser with a time of contract of sale prior to such first use,
supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such date of
first use.</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table">
<div style="display: table-row">
<div style="display: table-cell; width: 48px"><font style="font-family: Times New Roman; font-size: 13px">(c)&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">The undersigned
registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to section 13(a) or section
15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan&#x2019;s annual
report pursuant to section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial bona
fide offering thereof.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">II-3</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURES</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused
this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Ann Arbor,
State of Michigan, on this 10<font style="font-size: 70%; vertical-align: top">th</font> day of January
2020.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 336px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">ENDRA
Life Sciences Inc.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="display: table; margin-left: 336px">
<div style="display: table-row">
<div style="display: table-cell; width: 288px"><font style="font-family: Times New Roman; font-size: 13px">/<font style="text-decoration: underline">s/ Francois
Michelon</font></font></div>
</div>
</div>
<div style="text-align: left; margin-left: 336px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Francois
Michelon</font></div>
<div style="text-align: left; margin-left: 336px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer and Director</font></div>
<div style="text-align: left; margin-left: 336px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Principal
Executive Officer)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 312px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">POWER
OF ATTORNEY</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Each
person whose signature appears below constitutes and appoints
Francois Michelon and David R. Wells and each of them, his true and
lawful attorney-in-fact and agent, each with full power of
substitution and resubstitution, severally, for him and in his
name, place and stead, in any and all capacities, to sign any and
all amendments (including post-effective amendments) to this
registration statement, any subsequent registration statements
pursuant to Rule 462 of the Securities Act of 1933, as amended, and
to file the same, with all exhibits thereto and other documents in
connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them,
full power and authority to do and perform each and every act and
thing requisite and necessary to be done in and about the premises,
as fully to all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them or their or his or her
substitute or substitutes, may lawfully do or cause to be done by
virtue hereof. This power of attorney may be executed in
counterparts.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in
the capacities and on the dates indicated.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="width: 100%; font-family: Times New Roman; font-size: 13px">
<tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ Francois
Michelon</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Francois
Michelon</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Executive Officer and Director</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Principal
Executive Officer)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ David R.
Wells</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">David
R. Wells</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Chief
Financial Officer</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(Principal
Financial and Accounting Officer)</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ Anthony
DiGiandomenico</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Anthony
DiGiandomenico, Director</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ Sanjiv Gambhir,
M.D., Ph.D.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Sanjiv
Gambhir, M.D., Ph.D., Director</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ Michael
Harsh</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Michael
Harsh, Director</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 39%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Dated:
January 10, 2020</font></div>
</td>
<td style="vertical-align: top; width: 61%;">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="text-decoration: underline"><font style="font-family: Times New Roman; font-size: 13px">/s/ Alexander
Tokman</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Alexander
Tokman, Director</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">II-4</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ndra_ex51.htm
<DESCRIPTION>OPINION ON LEGALITY
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit 5.1</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ndra_ex51000.jpg"></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">January
10, 2020</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">ENDRA
Life Sciences Inc.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">3600
Green Court, Suite 350</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ann
Arbor, MI 48105</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Ladies
and Gentlemen:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">We have
acted as counsel to ENDRA Life Sciences Inc., a Delaware
corporation (the &#x201C;Company&#x201D;),<font style="font-size: 13px">&#xA0;</font>in connection with the Registration
Statement on Form S-3 (the &#x201C;Registration Statement&#x201D;)
filed on the date hereof with the Securities and Exchange
Commission (the &#x201C;SEC&#x201D;) under the Securities Act of
1933, as amended (the &#x201C;Securities Act&#x201D;), with respect
to the resale from time to time by the selling stockholders listed
in the Registration Statement under the heading &#x201C;Selling
Stockholders&#x201D; (the &#x201C;Selling Stockholders&#x201D;), as
detailed in the Registration Statement, of up to 25,644,002 shares
of the Company&#x2019;s common stock, $0.0001 par value per share
(&#x201C;Common Stock&#x201D;), comprising: (a) 904,526 shares (the
&#x201C;Issued Shares&#x201D;) issued pursuant to that certain
Securities Purchase Agreement, dated December 5, 2019 (the
&#x201C;Series A Purchase Agreement&#x201D;), in a private placement
that closed on December 11, 2019 (the &#x201C;First Private
Placement&#x201D;); (b) 7,191,873 shares (the &#x201C;Series A
Conversion Shares&#x201D;) issuable upon conversion of the
Company&#x2019;s Series A Convertible Preferred Stock, par value
$0.0001 per share (the &#x201C;Series A Preferred Stock&#x201D;),
issued in the First Private Placement; (c) 8,096,399 shares (the
&#x201C;Series A Warrant Shares&#x201D;) issuable upon exercise of
the warrants that were issued with the Series A Preferred Stock
(the &#x201C;Series A Warrants&#x201D;), including warrants issued to
the placement agent in the First Private Placement; (d) 8,660,410
shares (the &#x201C;Series A Dividend Shares&#x201D;) that may be
issuable in respect of accrued but unpaid dividends on shares of
Series A Preferred Stock; (e) 232,461 shares (the &#x201C;Series B
Conversion Shares&#x201D;) issuable upon conversion of the
Company&#x2019;s Series B Convertible Preferred Stock, par value
$0.0001 per share (the &#x201C;Series B Preferred Stock&#x201D;),
issued pursuant to that certain Securities Purchase Agreement,
dated December 19, 2019 (the &#x201C;Series B Purchase
Agreement&#x201D;), in a private placement that closed on December
23, 2019 (the &#x201C;Second Private Placement&#x201D;); (f) 278,948
shares (the &#x201C;Series B Warrant Shares&#x201D;) issuable upon
exercise of the warrants that were issued with the Series B
Preferred Stock (the &#x201C;Series B Warrants&#x201D;), including
warrants issued to the placement agent in the Second Private
Placement; and (g) 279,385 shares (the &#x201C;Series B Dividend
Shares&#x201D;) that may be issuable in respect of accrued but
unpaid dividends on shares of Series B Preferred Stock (all such
shares of Common Stock described in (a) through (g) above, the
&#x201C;Securities&#x201D;).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">You
have requested our opinion as to the matters set forth below in
connection with the Registration Statement. For purposes of
rendering that opinion, we have examined: (a) the Registration
Statement; (b) the Company&#x2019;s Fourth Amended and Restated
Certificate of Incorporation, as amended; (c) the Company&#x2019;s
Amended and Restated Bylaws; (d) the Series A Purchase Agreement;
(e) the Certificate of Designations of Series A Convertible
Preferred Stock, dated December 11, 2019 (the &#x201C;Series A
Certificate of Designations&#x201D;); (f) the Series A Warrants; (g)
the Series B Purchase Agreement; (h) the Certificate of
Designations of Series B Convertible Preferred Stock, dated
December 23, 2019 (the &#x201C;Series B Certificate of
Designations&#x201D;); (i) the Series B Warrants; (j) corporate
actions of the Company&#x2019;s Board of Directors that provide for
the execution, delivery and performance of the Series A Purchase
Agreement and the issuance of the Issued Shares, the Series A
Preferred Stock and the Series A Warrants pursuant thereto,
including the issuance of the Series A Conversion Shares and the
Series A Dividend Shares upon the conversion of such Series A
Preferred Stock and the issuance of the Series A Warrant Shares
upon the exercise of the Series A Warrants; (k) corporate actions
of the Company&#x2019;s Board of Directors that provide for the
execution, delivery and performance of the Series B Purchase
Agreement and the issuance of the Series B Preferred Stock and the
Series B Warrants pursuant thereto, including the issuance of the
Series B Conversion Shares and the Series B Dividend Shares upon
the conversion of such Series B Preferred Stock and the issuance of
the Series B Warrant Shares upon the exercise of the Series B
Warrants; and (l) a certificate of an officer of the Company, dated
as of the date hereof. Other than our review of the documents
listed in (a) through (l) above, we have not reviewed any other
documents or made any independent investigation for the purpose of
rendering this opinion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr"><br>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">1</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">For the
purposes of this opinion letter, we have assumed that: (a) each
document submitted to us is accurate and complete; (b) each such
document that is an original is authentic; (c) each such document
that is a copy conforms to an authentic original; (d) all
signatures on each such document are genuine; and (e) the Company
is and shall remain at all times a corporation duly incorporated,
validly existing and in good standing under the laws of the State
of Delaware. In rendering our opinion below, we have also assumed
that: (i) the Company will have sufficient authorized and unissued
shares of its Common Stock issuable upon conversion of the Series A
Preferred Stock and Series B Preferred Stock (including shares
issuable as Series A Dividend Shares and Series B Dividend Shares)
or issuable upon exercise of the Series A Warrants and Series B
Warrants on the date of such conversion of any Series A Preferred
Stock or Series B Preferred Stock or such exercise of any Series A
Warrants or Series B Warrants; (ii) the Company will have duly
authorized by corporate action each issuance of Series A Dividend
Shares or Series B Dividend Shares out of lawfully available funds
and such corporate action will not have been revoked; (iii) the
corporate actions of the Company referenced in clauses (j) and (k)
of the previous paragraph have not been, and will not be, revoked,
modified or amended; and (iv) the issuance of the Securities will
be noted in the Company&#x2019;s stock ledger. We have further
assumed the legal capacity of natural persons, and we have assumed
that each party to the documents we have examined or relied on has
the legal capacity or authority and has satisfied all legal
requirements that are applicable to that party to the extent
necessary to make such documents enforceable against that party. We
have not verified any of those assumptions.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">Our
opinion set forth below is limited to the Delaware General
Corporation Law (&#x201C;DGCL&#x201D;) and reported decisions
interpreting the DGCL.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">Based
upon and subject to the foregoing, it is our opinion
that:</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">1.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
issuance of the Issued Shares has been duly authorized and, the
Issued Shares are validly issued, fully paid and
non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">2.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
issuance of the Series A Conversion Shares has been duly authorized
and, when issued and delivered by the Company in accordance with
the Series A Certificate of Designations, the Series A Conversion
Shares will be validly issued, fully paid and
non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">3.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
issuance of the Series B Conversion Shares has been duly authorized
and, when issued and delivered by the Company in accordance with
the Series B Certificate of Designations, the Series B Conversion
Shares will be validly issued, fully paid and
non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">4.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
issuance of the Series A Warrant Shares has been duly authorized
and, when issued and delivered by the Company against payment
therefor, upon the exercise of the Series A Warrants in accordance
with the terms thereof, the Series A Warrant Shares will be validly
issued, fully paid, and non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">5.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;The
issuance of the Series B Warrant Shares has been duly authorized
and, when issued and delivered by the Company against payment
therefor, upon the exercise of the Series B Warrants in accordance
with the terms thereof, the Series B Warrant Shares will be validly
issued, fully paid, and non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">6.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;When
the Series A Dividend Shares have been duly authorized and declared
as dividends on the Series A Preferred Stock out of lawfully
available funds by all necessary action of the Company&#x2019;s
Board of Directors and issued pursuant to the Series A Certificate
of Designations and notation of the issuance of the Series A
Dividend Shares has been properly made in the Company&#x2019;s stock
ledger, the Series A Dividend Shares will be validly issued, fully
paid and non-assessable.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">7.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;When
the Series B Dividend Shares have been duly authorized and declared
as dividends on the Series B Preferred Stock out of lawfully
available funds by all necessary action of the Company&#x2019;s
Board of Directors and issued pursuant to the Series B Certificate
of Designations and notation of the issuance of the Series B
Dividend Shares has been properly made in the Company&#x2019;s stock
ledger, the Series B Dividend Shares will be validly issued, fully
paid and non-assessable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 13px"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">2</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">This
opinion is rendered solely in connection with the registration of
the Securities for resale by the Selling Stockholders under the
Registration Statement. This opinion is expressed as of the date
hereof, and we disclaim any undertaking to advise you of any
subsequent changes in the facts stated or assumed herein or of any
subsequent changes in applicable laws.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px">
<font style="font-family: Times New Roman; font-size: 13px">We
hereby consent to the filing of this opinion letter with the SEC as
Exhibit 5.1 to the Registration Statement. In giving our consent,
we do not thereby admit that we are in the category of persons
whose consent is required under Section 7 of the Securities Act or
the rules and regulations thereunder.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px;">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Very
truly yours,</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
K&amp;L Gates LLP</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;<br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">K&amp;L
Gates LLP</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pn" style="text-align: center"><font style="font-family: Times New Roman; font-size: 13px">3</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ndra_ex231.htm
<DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2020 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Exhibit 23.1</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We
consent to the incorporation by reference of our report dated March
11, 2019, which includes an explanatory paragraph regarding the
substantial doubt about the Company&#x2019;s ability to continue as
a going concern, in this Registration Statement of ENDRA Life
Sciences Inc. on Form S-3, with respect to our audits of the
consolidated financial statements of ENDRA Life Sciences Inc. as of
December 31, 2018 and 2017, and for the years ended December 31,
2018 and 2017, which appears in the <font style="color: #000000">Company&#x2019;s Annual Report on Form 10-K for the
year ended December 31, 2018,</font> which is part of this
Registration Statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">We also
consent to the reference to our Firm under the heading
&#x201C;Experts&#x201D; in this Registration Statement.</font></div>
<div>&#xA0;&#xA0;
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">/s/
RBSM LLP</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Henderson,
NV</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #000000; font-family: Times New Roman; font-size: 13px">
January 10, 2020</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font>
<font style="font-family: Times New Roman; font-size: 10"><br>
</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ndra_ex51000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ndra_ex51000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M%% !1110 4444 %%%% $L?W?QHHC^[^-%,"-NOX"DI6Z_@*2D 4444 %%%%
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MOM(M],TU(-BJ)!;@2#<H)(([\U@ZGI+Z+XF%BV2B3HT3?WD+#!_SZ5=\??\
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2HHI %%%% $L?W?QHHHJA'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ndra_s3000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ndra_s3000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !? 6(# 2(  A$! Q$!_\0
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MA)#F42CJ)#W/3';!&,5W%?.G[.>JR6GB'6M!G.WS8A,J,>0Z-M;]&_2OHN@
MKYR_:*U\7>OZ7X>27;%:Q_:)SC.'?@9^BC/_  *OHN1UBC:1V"HH+,3T %?+
M_@W3X/BG\:-1U+48/M&FAI+F2-B0"@^2)3_X[^1H ]-TCXQ_#K1M&LM,MM2G
M$-I"D*?Z')R%&,]*\>U#Q;H^G?&N/Q5X?N7DT^2Y6:7,9C(#C$HP1[L?QKZ"
M_P"%2^ _^A:M/^^G_P :\Q^-WPWT70_"UKK&@:9%9^1<>7<B,GYE?@$Y)Z,
M/^!4 ?0*,KHKH0RL,@CN*6N&^$7B'_A(OAOIDSONN+5?LDW/.4X!_%=I_&NY
MH **** "BBB@#G/#_P"[U&YB/4(/TKGO&G^C^--)N3T(C_1__KUT(;['XK8'
MA)>/S'^-9'Q*M6-G8WR#F*0H3Z9&1^HKAR7W8.D_LMHX,VBWAG)=+/[F:'Q"
M0MX5D(_AF0G\\?UJ]X.??X2TXYSB,J?P)%1:AC7_  -*Z?,T]J)!_O 9_F*S
M?AO?"?0YK0GYK>4D#_9;D?KFO:M?#-=F0I)8U2Z2CI^9S?@?_0_BCKMJ>K><
M!^$@/]:]%UY@-(ESW*C]:\XU%O\ A'_C/!<M\D%XRDGL0Z[3_P"/"N[\338M
MX8!]YFW$?3_]=<&?S4<+*IWC^.QUY:O><.TG_F7M$&-'@SZ$_J:YWPA^\UG4
M91]T@_JQKH+B0:7X>=CUB@Q_P+'^-9/@FV,>GW%P1_K9-H/L!_B37GTX.+H4
MOY5^EC:J^:K]YSGCW]_XST:W7EL("![R?_6KHOB+*L7@34MQ^^J(/J7%<V#_
M &Y\6<KS%:-U'_3,?_%&I_B_J(AT*ST]>9+F?>1WVH/\2*[Z>K;/'A-<F(J]
M&[?<K&O\,HC%X%LR?^6CR./IN/\ A77UE>&K Z7X:TZR((:*!0P/]XC)_4FM
M6M#U*$>2E&/9(****#4^9[3X1_$S1M:NM1T6>"SEF9U\R*\"L4+9QT]A^5:O
M_"(?''_H8'_\#Q_A7T'10!Y/\//#_P 3--\4"X\5ZJUSIGD.OEFZ\SYSC!QC
MZUZQ110 5X]\0_AUX@\2?$[1M>T^.W:QM! )2\P5ODE+-@?0U[#10 5%<6\-
MW;2VUQ&LL,J%)$89#*1@@_A4M% 'S@OP*\0Z7X]M[O3?LTNCV]_'/$[SX<1A
MPV"/4#CWQ7T?110 5B>,=+N=;\&ZQI=F$-S=VDD40=L#<1@9-;=% 'S5H'P_
M^,'@]9HM",,$<[!I D\+!B. ?GK8E\+?''6U\B^UQ+.)^&*W*1X'_;(9KWVB
M@#QSPC\ M,TN\74?$=Z=7N@V_P G:1#N]6SR_P".!Z@U[$JA5"J % P !TI:
M* "L#QOI-UKW@G5]*L0ANKJW:.,.VT9/J:WZ* /-O@WX+UCP3H.HV>LI"LL]
MT)4\J3>-NT#^8KTFBB@#Q+3/ACXE\/?&5_$>F16S:/)=N[ S -Y4@.\;3Z$G
M'T%>VT44 <_XXL]6U'P9J=AH:HVH74)A0O)L #<,<_[I-<E\&_A[?>!M*U%]
M62$:A=S*/W3[P(U''/U+?I7IM% !6/XJT-/$GA74]'?'^E6[(A/9\94_@P!K
M8HH \E^#/@KQ3X(EU.UUF*W%C=!9(S%,'*R#@\>X/_CM>M444 %%%% !1110
M!@>)+=@(;R/AD.UB.W<'\ZDU&W7Q'X7FB7'F21Y7VD'(_45K3P)<V[PR#*N,
M&N=TNY?2M1DLKDXC9L9/0'L?H:\N<OJF+]I]F?X-;"G!5(.$NIF_#O5-]I/I
M$_$D#%T4_P!TGYA^!_G67I[_ /")>/I;60[;2Y;:">FUCE3^!XJ3Q39S^&O$
ML.NV*_NIGW,!TW?Q*?9A_6M'Q990^)_#D&LZ?\\D*[L#J4_B7Z@_UKZ.C*/-
M9_#/3YGS\>=4_9?\O*3NO./_  Q2^+.C-<:3;:O"#YEF^V0CJ$;H?P;'YU:\
M,ZD_BQ[.\DZQ(!,/1EZ_F>?QJ&P\2IK7A9M,N1ONBGDRY'WX\8W?7M]:Y7P[
MJES\/?$]UINHQL;6=1G_ -D<?R/_ -:N#$488U/!ROS4FI>J[?J>I3KJE)8F
M/PU%;T?]:'?>,;YG\C2X/FDD8,X'_CH_.KU_=1>%/"1?(WPQ[$']Z0__ %^:
MS/#5G+J6I3:U><@,2F>A;U'L!7/:[>3>./%,&DV#'[# QS(.G^T_]!_]>N"B
MW)RK/=Z+T)Q6(=.%X_%+1(UOAII;I:76L3Y,ERVQ&/4J#DG\3_*N<E?_ (3O
MXIQI'\^G6!Y/4%$.2?\ @3<?2NB\>^(8/"_AZ/1=-(2ZFB\M%7K%'T+?4]!^
M)[5=^'7A@^']!\ZY3;?7F))0>J+_  K^'4^YKNC'E5C"%%>YA8[1UEZG8T44
M4SU@HHHH Y_P>[R:1,7=G/VEQECGTKH*YWP9_P @>;_KY?\ I714 <]?2./&
MVF('8(8')4,<'KVKH:YR_P#^1YTO_K@_]:Z.@#C-&TF/5Y-0DN+J\4QW3HHC
MF(&*Z73=+BTM)$BEGD#G),TFXCZ5S.A6%W=OJ+6^IRVBK=."J(#D^O-=5I]M
M/:6YCN+Q[IRQ/F.H! ].*8&+XH0S7FD6_FR1I-<%',;E3@XJQ%X7M(9DE6[O
MB48, TY(./6JWBF-IK[1HTD:)GN"!(O5>G(J[!HUW#<1R/K5Y*J,"4;;AO8\
M4 ;%%%%(#G-:EEN]=L](^TO;6\J&21D.&?K\H/X5>L= M].NQ<6]Q=?=(,;R
MEE;W(-2ZIH]KJT2K.&5T.8Y$.&4^U95M<:CHNKVVGWMQ]KM;G*PRL/G4CL:8
M&CKVJMI=B&A027,S".%/5C5*+PRUR@EU6_NI[AN6"2E57V %1^*"(M2T6XDX
MA2Y^8GH.G^%=+2 IZ=IT>F0-#'--(I;</-?<1[#VK+\02.FL:$%=E#7)# $C
M/3K705SOB+_D,Z#_ -?)_I0!T5<A9Z6FK:SK'VBYNE$-QA!',5&#FNOKD-/L
M)[W6]:,.H3VFVXY$6/FZ]<T ;^FZ1#I9D,4UQ)YF,^=)NQCTJ#Q0[1^'+QD9
ME8*,%3@_>%6M.L9K)9!-?3W>\@@RX^7Z8JGXK_Y%F]_W1_Z$* *_AJ_E ?2K
MUB;F!0R,3_K(R,@_AFG*[_\ "<.F]MGV,';GC.[TJ#5[.5+"QUBS'^E6<:E@
M/XTQR/\ /O26%W'?>+DNHCE); ,/;YNE,#;U74$TO39KN09V#Y5_O'L*QK71
M+G5H5N]7O+C=(-RP0OL6,'H..]2>-%8Z#N )5)D9L>E;T,B2P1R1D%'4,I'<
M4@*.FZ1#I;R&&:X=7 ^260L%^E9WB[<;>PC61T$ETJ,48@X-=%7-^+U+P:>H
M8H6NU 8=1[T 3KX5M%=6%W?_ "D'FX-;M8T>BWB2H[:Y>N%8$J=N&]NE;- '
M)VL!\1ZIJ!O;J98[:7RX[>.0J /4UOZ;IJ:9$\4<T\B,VX"5]VWV%4M1\.QW
M5T;VSN)+.\/62,\-]12:#J5W/-=:?J 4W5H0"ZCAP>AH VZ*** "LK6M,^VP
M>;$/W\8X_P!H>E:M%95Z,*U-TY[,#E[>6WUG3I-'U+JXVHQZY[?\"%<G8:A?
M^!]7GL+M/,MI.<=CZ.O]17<ZOHWV@FYM0!-U9<XW>_L:QY/#4OB&!Y+Z9E8#
M$4F06S_A[5PX;$UZ$U@ZT7)/:2[=_E_7GQXO!NK^_HNTX[>?D<G>V-YHUQ;^
M(+)%^S22;D(&5!]"/[I[5+K5O=?$1S-90*DUK'\JD]/52?<]/_UU:T[0-8DN
M)=!N7Q!$P=@7!0*?X@/?TJ#7/#FJ>&;KS-+N9#;W/[E75PK9/\)_Q_E7M49N
M247)\].UI?S)+9GER<XQ=50M"6\>S\OF8-CXPU=M!3PN$(E,GDJXX<KG'E_7
M/&?3BNV1[#X:^&C-<[)M5N1Q&#R[=E'HH[G_ .M6)??"N[.AK=03AM67YWAW
M80C^Z#_>'KT_G53PGX1O_%]^-5U^XDELX#Y0#R;FE*_P\=%'?U_6JKQI5$J\
M-&]UV95.%>,TY1]]JROLEU+G@?PY>>)=8;Q5KV9$+[X%<<2,.AQ_=7M]/:O6
M:;'&D4:QQHJ(@"JJC  '84ZN8]>A05&%EJ^K[A1110;A1110!RVGZ5XATN!X
M+:6P\MI&?Y]Q.3^%;FG#4A$_]I-;M)N^3R <8]\U=HH R;G3)YO$EEJ*L@A@
MB9&!)W$G/3\ZUJ** ,C0M+GTP7OG,C>?<-*NPG@'UK7HHH QM=TR\OI;&:R>
M%9+:0R?O<X)XQTJ-4\4;EW2Z;MSS@-TK=HH **** ,O4$UH72RZ=+:F': 8I
ME/7UR*K6VDW]SJ<.H:M-"6@!\F&$':I/<D]ZW:* *FHZ?!JED]K< E&Y!'53
MV(K(AM/$E@@@@N;2ZA7A&G!# >^*Z*B@"GIRWZP-_:+P-*6R/)!  ].:K:KI
MDU]J&F3Q,@6UF+N&)R1QT_*M6B@ KFETO7+/4;Z>QELA'=2[\2[B1Z=!72T4
M 9VG+K E?^TGM&CV_)Y .<^^:76[&74M'N+2%E620  N>.H-:%% $4$9CM8H
MGP2J!3Z'BL/3/#TFF:_-=1NAM&0B-,G<N2#CZ=:Z&B@"*XMXKJWD@F0/'(NU
ME/<5@0:7KFDCR=.NX+BU!^2.Y!!3VR*Z2B@#/TU=5W2-J3VV"!L2$'CUR35?
MQ!IESJ4%L+1XEDAF$O[PG''TK8HH P=GBG_GKIOY-6Z,[1GKCG%+10!A.GB6
M*218I;":-F)1G!4J,].*L:/I+Z>;BXN9A/>7+;I7 P/8#VK5HH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ndra_s3001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ndra_s3001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '( 5D# 2(  A$! Q$!_\0
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ME,W7[.O\JWJR>YLM@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>CU5T[3[72K&*SLX5B@C&%515EG5!EF"CU)Q6+=W<U2LK"T5%]I@_P">T?\
MWV*43Q-]V5#]&%(9)130Z'HZG\:7(]10 M%%% !1110 4444 %%%% !1110
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M*\!^(M51)8M-E$+8.Y^,BG<7*89..O%(2/6OH*#X0^%KZUMUN[F>"Y$0!!;
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M^?QMK<YQ]H"Y["LZ35=:NI!FYG//\.:[+_BF+,]8V(]LU&_BC0[7B&WW'V%
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M@"\DZ/WP:EK,[U*D[)]*0%ZBH4N%;KP:E!!Z&@!:*** "BBB@ HHHH ****
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MKF]-UF'4IF2$J54=176:.H\J1N^::6HF:=%%%62%%%% !1110 4444 %%%%
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MBM?)0GN6J*ND1TOB._@W:O.U[&"T<K$J?45K0Z/(V"Y"BN6^'WB>&'PA'%*
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M0F1DCZ4WW$CSK3KHQ/IE_/!-'$;F9F_=G*YQVK9U>^CUR[M(;))7\DM*[%"
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M'2K%QH$T_P!FF.H2B\M]P6?')!ZBA:6\O^"+>YF^*(7N-<M8(Y?*9[24!B<
M=*I2"&VL(4O]#>!(V7-U&W0YZUM_\(RUQ+)+J%[)<.8C$AZ; >N*:_AJZG@2
MUN=5FEM5(RA'W@.QHCI_7FP>IT28*+CICBEI% 50HZ 8I: "BBB@ HHHH *Y
M^^TK4!J=W=6#Q8NXA&XD'W<# (KH**+ <I#X5N$MTCDN$)6S,!('\1.<TZWT
M+59)[&2]N8BMI*K*BCC 7%=311?6_P#7]:AT,+5])NKK5+>]M_*<1QE#%*,K
MR<Y^M9UOX;U"VL2BO;,[7!F:,K\I![5UU%"T X]?#&H;))O.B2<3K-%&/N+@
M8Q4T_AZ_U%[NXO)8EGD14C"#@;3GG\:ZJB@#E9M"U6_N99[N:%=UJ8%5!W]:
MNWN@R7D&FQ&4!;9"DGOE=O%;M%'2P')?V#J[VUG923P"VM9E<,!RP!SBK7CG
MQ''X7\*W>H,V)-NR(>K'I71UX9\>;V:\U/1M A8CSF#$#U)Q1<"#X0^')-3N
M[CQ;J8,DDCD6^_GZM7I'B_Q-!X6T*6]E(,S#;$A[M5G0=/BTG1;.QA4*D,0&
M/?'->'^,]3N/'_Q%BT2T<FTBD\L8Z8'WFJ4[L;5CI?!*W'C3PY>#5Q)Y?VSS
MXI,XW#T'M78R6-O%$(HD"JHP *GTV*UTY(-/LU"P6R^40!4EVOENP-<[>K-4
MK(L>#X?*O[P <$"NPK$\-VIBM&G88:4Y'TK;K>"M$REN0RPEY5;/ J:BBJL(
M****8!1110 4444 %%%% !1110 5'//';0/-*P6-!N8GL*DK/UR."71;N.YD
M,<+1D,X[4GL-;E1/%.FN\:GSD61@JNT9"DGIS6WU&:XJ[?4['2H6N39W-DI1
M1A?FQV(]Z(M6OI8;;3EFV7D<K>8Q_NJ,C/YTV([0D $DX ZTB.LB!D8,IZ$&
MN!6XO(X$%Y=31R3AD+AMRN3TQ207,ND^#H9+>]>2ZF"J$+<J"3R* /0:*X*2
M[U6RANR'=(_LI<>8^2&XY%6GAOX[[2X?[2F(O$)FY^G2@#LZ*PO#\\_VC4+.
M:9I5MI=J,W7%;M !1110 4444 %%%% !1110 4444 %%%% !1110 5XS\4=)
MD'Q'\-ZHP)MV<1GCH0:]FJI>:9::@5^U1+)MY7<.A]:3 Y'Q%JW]F^&-1O%.
M&2%MI]^U>4?!2Q%SJ6IZQ*,N/E0GL2>:]&^)NFW4'@J^%O&9%8@$#J!7F7PB
MUZUTG[;I=\XMY)&WH7XR?2HU467HV>P2 !F90 2<FK45L-2,)# 8.'J*WM)K
M_88!^[8??[5TMGIT-G"JJ/F'4^M9Q@V[E.5BW&BQQJBC 48%.HHKH,@HHHH
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@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ndra_s3002.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ndra_s3002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 Z17AI9@  34T *@    @  U$0  $
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M-2E&9;ASEB:ZA5P,"I;25D$4V[L<H Z4M(*6H-0HHHH **** "BBB@ HHHH
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MHM8!NVC%.HI!ML'>EI,4M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "DI:*3 3%)M%+1BF W9VHVT^B@!,4"BEH ****
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M=\I;^57%.: '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[Q]J-KJ-Q$MO"0CE03UK:C0G6=H&%?$0H*\ST[/%130QS+MD0'G(SV->7_\
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MH%.4E42/HH"H;[_CPG_ZYG^53#I4-]_QXW'_ %S/\J^=ZGM(YCX:_P#(J_\
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MHR?>JVG7$]U!YTT?EEC\J]P* +<">7"B9R5&,U)@4+TI: &2*#&P/0C!KPV
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M@#K?M=O_ ,]XO^^Q_C1]KM_^>\7_ 'V*Y+_A6FB_WKC_ +^&@_#31<?>N/\
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M=[KS&DB*1AMJAN]7 @'3C-)L&*>*  # I:** "DQ2T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %(PRN*6B@"""W6W3:F>3GDU-2T4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@!"*3;^%.HH CV8Z5#)"K<LBL1
MZC-6J2BX612>QM9]K36T;D="5!H_L^U\T2FWC,@Z-L&15VEHN3RH@2)4)"*
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M,"K/_"RKJTT6TO[G1Y!:S?(DI;)=@/3WJ_XV\"W?BC1],L[>[CA-J#N9AG/
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M"YT][41PM*C.>),>E7+_ .(C6&AZ;J,FFL?MK;50N./2O./L']I:-I6EPP7
MOQ-ME_=GA"><^U>F>*/ TNM:?I5I:3)#'8X/(ZX% $-W\0+RP:..XT@I*R[B
MID'3'&*R+WXG3:IHUV-'LI?-CA+2RYXA/]:TM9\"ZE?ZRU];7D #0+'B12=I
M QD5BZ;\+-<TRWOH;?5+?;>)LD!3J* ,3PO\2KJRG OY[J\G92J1<;7:O2](
M\8R7VMMI-[8/:7!0.F6SN%<)8?!>^@F\^74HA+&=T)5>,^]=IH_A/48?$O\
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M'\XZ5#??#'4]5@1+F^LXG0[]T41^=L]ZDU3X=:OX@%N-2U*'%K%L@*(0<^]
M":O\6ETJZM8/[,,GGQ+)NW]"><5>B^)L:QW7VNQ=)8D1E16R&W=*YS5/A)K6
MI3Q22:E:CR55%PA' &*US\,KF5KMI;U 9(XA&4'\24 6/#/B+5-6\>W$-VCV
M]N;8.MNQZ>]>BH#W-<3X=\)ZI8>)9-7U&[AF9H!%\@QTKN!0 M%%% !1110
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MQG8X[D\]:CE^%-U/<M?M?0QW 8%844^7C\Z +_\ PM'_ $MK Z7(U_O"I&C
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M!KPGQ%J\TEQJUS!=RHT<IC >3DG_ &%]*QM$U2];09[IKN4SI>1*K%SR">:
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MHH **** "BBB@ HHHH **** &L,K7G=S\*+.Y\1S:RU]+YDL_G%<<?2O1J3
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M]Q)';\0@C[HKOQ<POG9*C8&3AJ:+RV/_ "VCX[[A0!QEU\-+.Y$8:\D&RW$
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MNY#&UQY^_'.?2NUQ1@4 >=W'PP@-G/;QW\HAD?S/+ [XKC9?"%XU@VGVEEJ
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ndra_s3003.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ndra_s3003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !@ 6D# 2(  A$! Q$!_\0
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MO)<;L8&XD^GO[5=TVT6WBDU;47 (!DR_\(_O&N4"W?C_ %YF)>'2K8\>P_\
MBC^@K@HX:OBI+$SDX);)=O/S9SXG%^P7LX+FG+1+]?1#K?6M?U"XFUV.)DM(
MCY<:A05"]Q[]LFC5O$^H^)RFDZ+;LI=,S$$<D=1GLOOWJMJ^I7MJ7\,6#+\S
MB-]IX&?X0>P/>I=0LI?A]!!J<<PEW (_;>_]S_=_PKU*+<8K$2@^:=DH=NEV
M>;*,]:*G>*^*7GU2(8/B3=Z-IES9ZK:O+J</R0[AMR>GS_3U'6L>S\2>*_#%
M_%K&KP2RV.IMYDB.H&[L,?W&QT!ZBDL?#&L>,[6_\37,@:9FS!%C_68Z@>@
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M/T&?YFL_XD7I@T6"U4\W$N3[JO/\\5H:#^]U6YF/= ?SKGOB!F;Q!I-L3\I
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MDPC_ .OR;^E=GXS\+6GC+PO=Z-=84RKNAEQS%(/NM^?7V)% '(>._$%GXJ^
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MH*LIP1\PJCX5_P!?K'_7XU6O%7_(LWO^Z/\ T(4 5;71KVXLX9CKU\#)&KD
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M'<&M*B@#G;>X\16]M%"-)MR(T" FX'.!BMNT>XDM8WNHEBG(^=%;< ?K4]%
M&1=V-Q+XFL+U$!@AB=7;<.">G%3ZSIBZKI[P9VRJ=\3_ -UATK0HH QO#-C=
M:?I;17B!9FF9R P/7'I4FMZ.-5AC:*7R;N!MT,H['T/M6K10!S\5]XC@7RY]
M*BN'''FQS!0??!K7L7NY+56OH8X9R3E$;< .W-6:* .=U2SU,>(K?4K&VCG6
M. QD/(%Y)/\ C5FVN]>>YC6XTR".$MAW6<$J/7%;-% #)?,\E_*"F3:=@;IG
MMFL/[?XC\ORO[(A\[&/-$XV?7'6M^B@#+T+2VTJP,<L@DGE<R2L.FX^E:E%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
